EXHIBIT 3.1
THIRD AMENDED AND RESTATED
BYLAWS
OF
NORTHWEST BIOTHERAPEUTICS, INC.
Adopted
June 15, 2007
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page
|
PREAMBLE
|
|
|
1
|
|
|
|
|
|
|
ARTICLE I OFFICERS AND RECORDS
|
|
|
1
|
|
|
|
|
|
|
Section 1.1 Registered Office and Agent
|
|
|
1
|
|
Section 1.2 Other Offices
|
|
|
1
|
|
Section 1.3 Books and Records
|
|
|
1
|
|
|
|
|
|
|
ARTICLE II MEETINGS OF STOCKHOLDERS
|
|
|
1
|
|
|
|
|
|
|
Section 2.1 Annual Meetings
|
|
|
1
|
|
Section 2.2 Special Meetings
|
|
|
2
|
|
Section 2.3 Place of Meetings
|
|
|
2
|
|
Section 2.4 Notice of Meetings
|
|
|
2
|
|
Section 2.5 Voting List
|
|
|
2
|
|
Section 2.6 Quorum and Adjournment
|
|
|
3
|
|
Section 2.7 Adjourned Meetings
|
|
|
3
|
|
Section 2.8 Voting
|
|
|
3
|
|
Section 2.9 Proxies
|
|
|
4
|
|
Section 2.10 Record Date
|
|
|
5
|
|
Section 2.11 Conduct of Meetings; Agenda
|
|
|
5
|
|
Section 2.12 Inspectors of Election; Opening and Closing of Polls
|
|
|
5
|
|
Section 2.13 Procedures for Bringing Business Before Annual Meetings
|
|
|
6
|
|
Section 2.14 Action Without Meeting
|
|
|
7
|
|
|
|
|
|
|
ARTICLE III
BOARD OF DIRECTORS POWERS, NUMBER, CLASSIFICATION, NOMINATIONS,
RESIGNATIONS,
REMOVAL, VACANCIES AND COMPENSATION
|
|
|
8
|
|
|
|
|
|
|
Section 3.1 Management
|
|
|
8
|
|
Section 3.2 Number and Qualification
|
|
|
8
|
|
Section 3.3 Classes of Directors
|
|
|
8
|
|
Section 3.4 Election; Term of Office
|
|
|
8
|
|
Section 3.5 Allocation of Directors Among Classes In The Event of
Increases or Decreases In The Number of Directors
|
|
|
8
|
|
Section 3.6 Nominations
|
|
|
9
|
|
Section 3.7 Resignations
|
|
|
10
|
|
Section 3.8 Removal
|
|
|
11
|
|
Section 3.9 Vacancies
|
|
|
11
|
|
Section 3.10 Subject to Rights of Holders of Preferred Stock
|
|
|
11
|
|
Section 3.11 Compensation
|
|
|
12
|
|
|
|
|
|
|
ARTICLE IV
BOARD OF DIRECTORS MEETINGS AND ACTIONS
|
|
|
12
|
|
|
|
|
|
|
Section 4.1 Place of Meetings
|
|
|
12
|
|
Section 4.2 Regular Meetings
|
|
|
12
|
|
Section 4.3 Special Meetings
|
|
|
12
|
|
- i -
|
|
|
|
|
|
|
Page
|
Section 4.4 Quorum; Voting
|
|
|
12
|
|
Section 4.5 Conduct of Meetings
|
|
|
13
|
|
Section 4.6 Presumption of Assent
|
|
|
13
|
|
Section 4.7 Action Without Meeting
|
|
|
13
|
|
Section 4.8 Telephonic Meetings
|
|
|
13
|
|
|
|
|
|
|
ARTICLE V COMMITTEES OF THE BOARD OF DIRECTORS
|
|
|
13
|
|
|
|
|
|
|
Section 5.1 Executive Committee
|
|
|
13
|
|
Section 5.2 Other Committees
|
|
|
14
|
|
Section 5.3 Term
|
|
|
14
|
|
Section 5.4 Committee Changes; Removal
|
|
|
14
|
|
Section 5.5 Alternate Members
|
|
|
14
|
|
Section 5.6 Rules and Procedures
|
|
|
14
|
|
Section 5.7 Presumption of Assent
|
|
|
15
|
|
Section 5.8 Action Without Meeting
|
|
|
15
|
|
Section 5.9 Telephonic Meetings
|
|
|
15
|
|
Section 5.10 Resignations
|
|
|
15
|
|
Section 5.11 Limitations on Authority
|
|
|
15
|
|
|
|
|
|
|
ARTICLE VI OFFICERS
|
|
|
16
|
|
|
|
|
|
|
Section 6.1 Number; Titles; Qualification; Term of Office
|
|
|
16
|
|
Section 6.2 Election
|
|
|
16
|
|
Section 6.3 Removal
|
|
|
16
|
|
Section 6.4 Resignations
|
|
|
17
|
|
Section 6.5 Vacancies
|
|
|
17
|
|
Section 6.6 Salaries
|
|
|
17
|
|
Section 6.7 Chairman of The Board
|
|
|
17
|
|
Section 6.8 Chief Executive Officer
|
|
|
17
|
|
Section 6.9 President
|
|
|
17
|
|
Section 6.10 Chief Scientific Officer
|
|
|
18
|
|
Section 6.11 Vice Presidents
|
|
|
18
|
|
Section 6.12 Treasurer
|
|
|
18
|
|
Section 6.13 Assistant Treasurers
|
|
|
18
|
|
Section 6.14 Secretary
|
|
|
19
|
|
Section 6.15 Assistant Secretaries
|
|
|
19
|
|
|
|
|
|
|
ARTICLE VII STOCK
|
|
|
19
|
|
|
|
|
|
|
Section 7.1 Certificates
|
|
|
19
|
|
Section 7.2 Signatures on Certificates
|
|
|
19
|
|
Section 7.3 Legends
|
|
|
20
|
|
Section 7.4 Lost, Stolen or Destroyed Certificates
|
|
|
20
|
|
Section 7.5 Transfers of Shares
|
|
|
20
|
|
Section 7.6 Registered Stockholders
|
|
|
21
|
|
Section 7.7 Regulations
|
|
|
21
|
|
Section 7.8 Stock Options, Warrants, etc.
|
|
|
21
|
|
- ii -
|
|
|
|
|
|
|
Page
|
ARTICLE VIII INDEMNIFICATION
|
|
|
21
|
|
|
|
|
|
|
Section 8.1 Third Party Actions
|
|
|
21
|
|
Section 8.2 Actions By or In The Right of The Corporation
|
|
|
22
|
|
Section 8.3 Expenses
|
|
|
22
|
|
Section 8.4 Non-Exclusivity
|
|
|
23
|
|
Section 8.5 Enforceability
|
|
|
23
|
|
Section 8.6 Insurance
|
|
|
23
|
|
Section 8.7 Survival
|
|
|
23
|
|
Section 8.8 Amendment
|
|
|
23
|
|
Section 8.9 Definitions
|
|
|
24
|
|
|
|
|
|
|
ARTICLE IX NOTICES AND WAIVERS
|
|
|
24
|
|
|
|
|
|
|
Section 9.1 Methods of Giving Notices
|
|
|
24
|
|
Section 9.2 Waiver of Notice
|
|
|
24
|
|
|
|
|
|
|
ARTICLE X BENEFICIAL OWNERSHIP NOTICES
|
|
|
25
|
|
|
|
|
|
|
Section 10.1 OWNERSHIP NOTICE
|
|
|
25
|
|
Section 10.2 DISCLOSURE NOTICE
|
|
|
25
|
|
Section 10.3 EFFECT OF DISCLOSURE NOTICE
|
|
|
25
|
|
|
|
|
|
|
ARTICLE XI MISCELLANEOUS PROVISIONS
|
|
|
27
|
|
|
|
|
|
|
Section 11.1 Dividends
|
|
|
27
|
|
Section 11.2 Reserves
|
|
|
27
|
|
Section 11.3 Checks
|
|
|
27
|
|
Section 11.4 Corporate Contracts and Instruments
|
|
|
27
|
|
Section 11.5 Attestation
|
|
|
27
|
|
Section 11.6 Securities of Other Corporations
|
|
|
27
|
|
Section 11.7 Fiscal Year
|
|
|
28
|
|
Section 11.8 Seal
|
|
|
28
|
|
Section 11.9 Invalid Provisions
|
|
|
28
|
|
Section 11.10 Headings
|
|
|
28
|
|
Section 11.11 References/Gender/Number
|
|
|
28
|
|
Section 11.12 Amendments
|
|
|
28
|
|
|
|
|
|
|
CERTIFICATE OF SECRETARY
|
|
|
28
|
|
- iii -
THIRD AMENDED AND RESTATED BYLAWS
OF NORTHWEST BIOTHERAPEUTICS, INC.
PREAMBLE
These Bylaws are subject to, and governed by, the General Corporation Law of the State of
Delaware (DGCL) and the Certificate of Incorporation (Certificate of Incorporation) of
Northwest Biotherapeutics, Inc. (Corporation). In the event of a direct conflict between the
provisions of these Bylaws and the mandatory provisions of the DGCL or the provisions of the
Certificate of Incorporation, such provisions of the DGCL and the Certificate of Incorporation, as
the case may be, will be controlling.
ARTICLE I
OFFICERS AND RECORDS
SECTION 1.1 REGISTERED OFFICE AND AGENT. The registered office and registered agent of the
Corporation shall be as designated from time to time by the appropriate filing by the Corporation
in the office of the Secretary of State of the State of Delaware.
SECTION 1.2 OTHER OFFICES. The Corporation may also have offices at such other places, both
within and without the State of Delaware, as the Board of Directors of the Corporation (Board of
Directors) may from time to time determine or the business of the Corporation may require.
SECTION 1.3 BOOKS AND RECORDS. The books and records of the Corporation may be kept at the
Corporations principal executive office or at such other locations as may from time to time be
designated by the Board of Directors. Consents and notices may be received in the form of
electronic communications provided that they are reproduced in paper form and delivered to the
Corporations principal executive office unless otherwise provided in the Certificate of
Incorporation or the DGCL. The use of reproductions of consents including, but not limited to
copies, faxes, and other reliable reproductions, may be used in lieu of the original writing for
any and all purposes for which the original writing could be used, provided the reproduction is a
complete reproduction of the entire original writing pursuant to the DGCL.
ARTICLE II
MEETINGS OF STOCKHOLDERS
SECTION 2.1 ANNUAL MEETINGS. An annual meeting of the Corporations stockholders (the
Stockholders) shall be held each calendar year for the purposes of (i) electing directors as
provided in Article III and (ii) transacting such other business as may properly be brought before
the meeting. Each annual meeting shall be held on such date (no later than 13 months after the
date of the last annual meeting of Stockholders) and at such time as shall be designated by the
Board of Directors and stated in the notice or waivers of notice of such meeting.
SECTION 2.2 SPECIAL MEETINGS. Special meetings of the Stockholders, for any purpose or
purposes, may be called at any time by the Chairman of the Board (if any) or the Chief Executive
Officer and shall be called by the Secretary at the written request, or by resolution adopted by
the affirmative vote of a majority of the Corporations directors, which request or resolution
shall fix the date, time and place, and state the purpose or purposes, of the proposed meeting.
Except as provided by applicable law, these Bylaws, or the Certificate of Incorporation,
Stockholders shall not be entitled to call a special meeting of Stockholders or to require the
Board of Directors or any officer to call such a meeting or to propose business at such a meeting.
Business transacted at any special meeting of Stockholders shall be limited to the purposes stated
in the notice or waivers of notice of such meeting.
SECTION 2.3 PLACE OF MEETINGS. The Board of Directors may designate the place of meeting
(either within or without the State of Delaware) for any meeting of Stockholders. If no
designation is made by the Board of Directors, the place of meeting shall be held at the principal
executive office of the Corporation.
SECTION 2.4 NOTICE OF MEETINGS. (a) Written or electronic notice of each meeting of
Stockholders shall be delivered to each Stockholder of record entitled to vote thereat, which
notice shall (i) state the place, date and time of the meeting and, in the case of a special
meeting, the purpose or purposes for which the meeting is called and (ii) be given not less than 10
nor more than 60 days before the date of the meeting.
(b) Each notice of a meeting of Stockholders shall be given as provided in Section 9.1, except
that if no address appears on the Corporations books or stock transfer records with respect to any
Stockholder, notice to such Stockholder shall be deemed to have been given if sent by first-class
mail or telecommunication to the Corporations principal executive office or if published at least
once in a newspaper of general circulation in the county where such principal executive office is
located.
(c) If any notice addressed to a Stockholder at the address of such Stockholder appearing on
the books of the Corporation is returned to the Corporation by the United States Postal Service
marked to indicate that the United States Postal Service is unable to deliver the notice to the
Stockholder at such address, all further notices to such Stockholder at such address shall be
deemed to have been duly given without further mailing if the same shall be available to such
Stockholder upon written demand of such Stockholder at the principal executive office of the
Corporation for a period of one year from the date of the giving of such notice.
(d) Any previously scheduled meeting of the Stockholders may be postponed by resolution of the
Board of Directors upon public notice given prior to the time previously scheduled for such
meeting.
SECTION 2.5 VOTING LIST. At least 10 days before each meeting of Stockholders, the Secretary
or other officer or agent of the Corporation who has charge of the Corporations stock ledger shall
prepare a complete list of the Stockholders entitled to vote at such meeting, arranged in
alphabetical order and showing, with respect to each Stockholder, his address and the number of
shares registered in his name. Such list shall be open to the examination of any Stockholder, for
any purpose germane to the meeting, during ordinary business hours, for a
- 2 -
period of at least 10 days prior to the meeting, either at a place within the city where the
meeting is to be held, which place shall be specified in the notice or waivers of notice of the
meeting or, if not so specified, at the place where the meeting is to be held. The list shall also
be produced and kept open at the time and place of the meeting during the whole time thereof, and
may be inspected by any Stockholder who is present. The stock ledger of the Corporation shall be
the only evidence as to who are the Stockholders entitled to examine any list required by this
Section 2.5 or to vote at any meeting of Stockholders.
SECTION 2.6 QUORUM AND ADJOURNMENT. The holders of a majority of the voting power of the
outstanding shares of the Corporation entitled to vote generally in the election of directors (the
Voting Stock), present in person or by proxy, shall constitute a quorum at any meeting of
Stockholders, except as otherwise provided by applicable law, the Certificate of Incorporation, or
these Bylaws. If a quorum is present at any meeting of Stockholders, such quorum shall not be
broken by the withdrawal of enough Stockholders to leave less than a quorum and the remaining
Stockholders may continue to transact business until adjournment. If a quorum shall not be present
at any meeting of Stockholders, the holders of a majority of the voting stock represented at such
meeting or, if no Stockholder entitled to vote is present at such meeting, any officer of the
Corporation may adjourn such meeting from time to time until a quorum shall be present.
Notwithstanding anything in these Bylaws to the contrary, the chairman of any meeting of
Stockholders shall have the right, acting in his sole discretion, to adjourn such meeting from time
to time.
SECTION 2.7 ADJOURNED MEETINGS. When a meeting of Stockholders is adjourned to another time
or place, unless otherwise provided by these Bylaws, notice need not be given of the adjourned
meeting if the time and place thereof are announced at the meeting at which the adjournment is
taken; provided, however, if an adjournment is for more than 30 days or if after an adjournment a
new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be
given to each Stockholder entitled to vote thereat. At any adjourned meeting at which a quorum
shall be present in person or by proxy, the Stockholders entitled to vote thereat may transact any
business which might have been transacted at the meeting as originally noticed.
SECTION 2.8 VOTING. (a) Election of directors at all meetings of Stockholders at which
directors are to be elected shall be by written ballot or electronic communications and, except as
otherwise provided in the Certificate of Incorporation, a plurality of the votes cast thereat shall
elect. Except as otherwise provided by applicable law, the Certificate of Incorporation or these
Bylaws, all matters other than the election of directors submitted to the Stockholders at any
meeting shall be decided by a majority of the votes cast with respect to such matter. Except as
otherwise provided in the Certificate of Incorporation or by applicable law, (i) no Stockholder
shall have any right of cumulative voting and (ii) each outstanding share, regardless of class,
shall be entitled to one vote on each matter submitted to a vote at a meeting of Stockholders.
(b) Shares standing in the name of another corporation (whether domestic or foreign) may be
voted by such officer, agent or proxy as the bylaws of such corporation may prescribe or, in the
absence of such provision, as the board of directors of such corporation may determine. Shares
standing in the name of a deceased person may be voted by the executor or administrator
- 3 -
of such deceased person, either in person or by proxy. Shares standing in the name of a
guardian, conservator, or trustee may be voted by such fiduciary, either in person or by proxy, but
no fiduciary shall be entitled to vote shares held in such fiduciary capacity without a transfer of
such shares into the name of such fiduciary. Shares standing in the name of a receiver may be
voted by such receiver. A Stockholder whose shares are pledged shall be entitled to vote such
shares, unless in the transfer by the pledgor on the books of the Corporation he has expressly
empowered the pledgee to vote thereon, in which case only the pledgee (or his proxy) may represent
the stock and vote thereon.
(c) If shares or other securities having voting power stand of record in the name of two or
more persons (whether fiduciaries, members of a partnership, joint tenants, tenants in common,
tenants by the entirety or otherwise) or if two or more persons have the same fiduciary
relationship respecting the same shares, unless the Secretary is given written notice to the
contrary and is furnished with a copy of the instrument or order appointing them or creating the
relationship wherein it is so provided, their acts with respect to voting shall have the following
effect:
(i) if only one votes, his act binds all;
(ii) if more than one votes, the act of the majority so voting binds all; and
(iii) if more than one votes but the vote is evenly split on any particular matter, each
faction may vote the securities in question proportionately or any person voting the shares, or a
beneficiary, (if any) may apply to the Delaware Court of Chancery or such other court as may have
jurisdiction to appoint an additional person to act with the person so voting the shares, which
shall then be voted as determined by a majority such persons and the person so appointed by the
court.
If the instrument so filed shows that any such tenancy is held in unequal interests, a majority or
even-split for the purpose of the paragraph (c) shall be a majority or even-split in interest.
SECTION 2.9 PROXIES. (a) At any meeting of Stockholders, each Stockholder having the right
to vote thereat may be represented and vote either in person or by proxy executed in writing by
such Stockholder or by his duly authorized attorney-in-fact. Each such proxy shall be filed with
the Secretary of the Corporation at or before the beginning of each meeting at which such proxy is
to be voted. Unless otherwise provided therein, no proxy shall be valid after three years from the
date of its execution. Each proxy shall be revocable unless expressly provided therein to be
irrevocable and coupled with an interest sufficient in law to support an irrevocable power or
unless otherwise made irrevocable by applicable law.
(b) A proxy shall be deemed signed if the Stockholders name is placed on the proxy (whether
by manual signature, telegraphic transmission or otherwise) by the Stockholder or his
attorney-in-fact. In the event any proxy shall designate two or more persons to act as proxies, a
majority of such persons present at the meeting (or, if only one shall be present, then that one)
shall have and may exercise all the powers conferred by the proxy upon all the persons so
designated unless the proxy shall otherwise provide.
- 4 -
(c) Except as otherwise provided by applicable law, by the Certificate of Incorporation or by
these Bylaws, the Board of Directors may, in advance of any meeting of Stockholders, prescribe
additional regulations concerning the manner of execution and filing of proxies (and the validation
of same) which may be voted at such meeting.
SECTION 2.10 RECORD DATE. For the purpose of determining the Stockholders entitled to notice
of or to vote at any meeting of Stockholders (or any adjournment thereof) or to receive payment of
any dividend or other distribution or allotment of any rights or to exercise any rights in respect
of any change, conversion or exchange of stock or for the purpose of any other lawful action, the
Board of Directors may fix a record date, which record date shall not precede the date on which the
resolution fixing the record date is adopted by the Board of Directors or be more than 60 nor less
than 10 days prior to the date of such meeting nor more than 60 days prior to any other action. If
no record date is fixed, (i) the record date for determining Stockholders entitled to notice of or
to vote at a meeting of Stockholders shall be at the close of business on the day next preceding
the day on which notice is given or, if notice is waived, at the close of business on the day next
preceding the day on which the meeting is held and (ii) the record date for determining
Stockholders for any other purpose shall be at the close of business on the day on which the Board
of Directors adopts the resolution relating thereto. A determination of Stockholders of record
entitled to notice of or to vote at a meeting of Stockholders shall apply to any adjournment of the
meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned
meeting.
SECTION 2.11 CONDUCT OF MEETINGS; AGENDA. (a) Meetings of the Stockholders shall be presided
over by the officer of the Corporation whose duties under these Bylaws require him to do so;
provided, however, if no such officer of the Corporation shall be present at any meeting of
Stockholders, such meeting shall be presided over by a chairman to be chosen by a majority of the
Stockholders entitled to vote at the meeting who are present in person or by proxy. At each
meeting of Stockholders, the officer of the Corporation whose duties under these Bylaws require him
to do so shall act as secretary of the meeting; provided, however, if no such officer of the
Corporation shall be present at any meeting of Stockholders, the chairman of such meeting shall
appoint a secretary. The order of business at each meeting of Stockholders shall be as determined
by the chairman of the meeting, including such regulation of the manner of voting and the conduct
of discussion as seems to him in order.
(b) The Board of Directors may, in advance of any meeting of Stockholders, adopt an agenda for
such meeting, adherence to which the chairman of the meeting may enforce.
SECTION 2.12 INSPECTORS OF ELECTION; OPENING AND CLOSING OF POLLS. (a) Before any meeting of
Stockholders, the Board of Directors may, and if required by law shall, appoint one or more persons
to act as inspectors of election at such meeting or any adjournment thereof. If any person
appointed as inspector fails to appear or fails or refuses to act, the chairman of the meeting may,
and if required by law or requested by any Stockholder entitled to vote or his proxy shall, appoint
a substitute inspector. If no inspectors are appointed by the Board of Directors, the chairman of
the meeting may, and if required by law or requested by any Stockholder entitled to vote or his
proxy shall, appoint one or more inspectors at the meeting. Notwithstanding the foregoing,
inspectors shall be appointed consistent with the mandatory provisions of Section 231 of the DGCL.
- 5 -
(b) Inspectors may include individuals who serve the Corporation in other capacities
(including as officers, employees, agents or representatives); provided, however, that no director
or candidate for the office of director shall act as an inspector. Inspectors need not be
Stockholders.
(c) The inspectors shall (i) determine the number of shares of capital stock of the
Corporation outstanding and the voting power of each, the number of shares represented at the
meeting, the existence of a quorum and the validity and effect of proxies and (ii) receive votes or
ballots, hear and determine all challenges and questions arising in connection with the right to
vote, count and tabulate all votes and ballots, determine the results and do such acts as are
proper to conduct the election or vote with fairness to all Stockholders. On request of the
chairman of the meeting, the inspectors shall make a report in writing of any challenge, request or
matter determined by them and shall execute a certificate of any fact found by them. The
inspectors shall have such other duties as may be prescribed by Section 231 of the DGCL.
(d) The chairman of the meeting may, and if required by the DGCL shall, fix and announce at
the meeting the date and time of the opening and the closing of the polls for each matter upon
which the Stockholders will vote at the meeting.
SECTION 2.13 PROCEDURES FOR BRINGING BUSINESS BEFORE ANNUAL MEETINGS. (a) Notwithstanding
anything in these Bylaws to the contrary, no business shall be conducted at an annual meeting of
Stockholders except in accordance with the procedures hereinafter set forth in this Section 2.13;
provided, however, that nothing in this Section 2.13 shall be deemed to preclude discussion by any
Stockholder of any business properly brought before any annual meeting of Stockholders in
accordance with such procedures.
(b) At any annual meeting of Stockholders, only such business shall be conducted as shall have
been properly brought before the meeting. To be properly brought before an annual meeting,
business must be (i) specified in the notice of meeting (or any supplement thereto) given by or at
the direction of the Board of Directors, (ii) otherwise properly brought before the meeting by or
at the direction of the Board of Directors or (iii) properly brought before the meeting by a
Stockholder. In addition to any other applicable requirements, for business to be properly brought
before an annual meeting by a Stockholder, the Stockholder must have given timely notice thereof in
writing to the Secretary. To be timely, a Stockholders notice must be delivered to or mailed and
received at the principal executive office of the Corporation not less than 120 days nor more than
150 days in advance of the first anniversary of the date of the Corporations proxy statement
released to Stockholders in connection with the previous years annual meeting of Stockholders;
provided, however, that if no annual meeting was held in the previous year or the date of the
annual meeting of Stockholders has been changed by more than 30 calendar days from the date
contemplated at the time of the previous years proxy statement, the notice must be received by the
Corporation at least 80 days prior to the date the Corporation intends to distribute its proxy
statement with respect to such meeting. Any meeting of Stockholders which is adjourned and will
reconvene within 30 days after the meeting date as originally noticed shall, for purposes of any
Stockholders notice contemplated by this paragraph (b), be deemed to be a continuation of the
original meeting, and no business may be brought before such adjourned meeting by any Stockholder
unless timely notice of such business was given to the Secretary of the Corporation for the meeting
as originally noticed.
- 6 -
(c) Each notice given by a Stockholder as contemplated by paragraph (b) above shall set forth,
as to each matter the Stockholder proposes to bring before the annual meeting, (i) the nature of
the proposed business with reasonable particularity, including the exact text of any proposal to be
presented for adoption and any supporting statement, which proposal and supporting statement shall
not in the aggregate exceed 500 words, and his reasons for conducting such business at the annual
meeting, (ii) any material interest of the Stockholder in such business, (iii) the name, principal
occupation and record address of the Stockholder, (iv) the class and number of shares of the
Corporation which are held of record or beneficially owned by the Stockholder, (v) the dates upon
which the Stockholder acquired such shares of stock and documentary support for any claims of
beneficial ownership and (vi) such other matters as may be required by the Certificate of
Incorporation.
(d) The foregoing right of a Stockholder to propose business for consideration at an annual
meeting of Stockholders shall be subject to such conditions, restrictions and limitations as may be
imposed by the Certificate of Incorporation. Nothing in this Section 2.13 shall entitle any
Stockholder to propose business for consideration at any special meeting of Stockholders.
(e) The chairman of any meeting of Stockholders shall determine whether business has been
properly brought before the meeting and, if the facts so warrant, may refuse to transact any
business at such meeting which has not been properly brought before the meeting.
(f) Notwithstanding any other provision of these Bylaws, the Corporation shall be under no
obligation to include any Stockholder proposal in its proxy statement or otherwise present any such
proposal to Stockholders at a meeting of Stockholders if the Board of Directors reasonably believes
that the proponents thereof have not complied with Sections 13 and 14 of the Securities Exchange
Act of 1934, as amended (the Exchange Act), and the rules and regulations promulgated thereunder,
and the Corporation shall not be required to include in its proxy statement to Stockholders any
Stockholder proposal not required to be included in its proxy statement to Stockholders in
accordance with the Exchange Act and such rules or regulations.
(g) Nothing in this Section 2.13 shall be deemed to affect any rights of Stockholders to
request inclusion of proposals in the Corporations proxy statement pursuant to Rule 14a-8 of the
Exchange Act.
(h) Reference is made to Section 3.4 for procedures relating to the nomination of any person
for election or reelection as a director of the Corporation.
SECTION 2.14 ACTION WITHOUT MEETING. No action shall be taken by Stockholders except at a
meeting of Stockholders. Stockholders may not act by written consent in lieu of a meeting.
- 7 -
ARTICLE III
BOARD OF DIRECTORS POWERS, NUMBER,
CLASSIFICATION, NOMINATIONS, RESIGNATIONS,
REMOVAL, VACANCIES AND COMPENSATION
SECTION 3.1 MANAGEMENT. The business and property of the Corporation shall be managed by and
under the direction of the Board of Directors. In addition to the powers and authorities expressly
conferred upon the Board of Directors by these Bylaws, the Board of Directors may exercise all the
powers of the Corporation and do all such lawful acts and things as are not by law, by the
Certificate of Incorporation or by these Bylaws directed or required to be exercised or done by the
Stockholders.
SECTION 3.2 NUMBER AND QUALIFICATION. The number of directors shall be fixed from time to
time exclusively pursuant to resolution adopted by a majority of the Corporations directors, but
shall consist of not less than one nor more than seven directors, subject, however, to increases
above seven members as may be required in order to permit the holders of any series of preferred
stock of the Corporation to elect directors under specified circumstances. The directors need not
be Stockholders or residents of the State of Delaware. Each director must have attained 21 years
of age.
SECTION 3.3 CLASSES OF DIRECTORS. The Board of Directors shall be divided into three classes
designated as Class I, Class II and Class III, respectively, all as nearly equal in number as
possible, with each director then in office receiving the classification to be determined with
respect to such director by the Board of Directors.
SECTION 3.4 ELECTION; TERM OF OFFICE. (a) The initial term of office of Class I directors
shall expire at the annual meeting of the Corporations Stockholders in 2002. The initial term of
office of Class II directors shall expire at the annual meeting of Stockholders in 2003. The
initial term of office of Class III directors shall expire at the annual meeting of Stockholders in
2004. Subject to Sections 3.9 and 3.10, each director elected at an annual meeting of Stockholders
to succeed a director whose term is expiring shall hold office until the third annual meeting of
Stockholders after his election and until his successor is elected and qualified or until his
earlier death, resignation or removal.
(b) Directors shall be elected by Stockholders only at annual meetings of Stockholders, except
that if any such annual meeting is not held or if any director to be elected thereat is not
elected, such director may be elected at any special meeting of Stockholders held for that purpose.
(c) No decrease in the number of directors constituting the Board of Directors shall have the
effect of shortening the term of any incumbent director.
SECTION 3.5 ALLOCATION OF DIRECTORS AMONG CLASSES IN THE EVENT OF INCREASES OR DECREASES IN
THE NUMBER OF DIRECTORS. In the event of any increase or decrease in the authorized number of
directors, (i) each director then serving as such shall nevertheless continue as a director of the
class of which he is a member and
- 8 -
(ii) the newly created or eliminated directorships resulting from such increase or decrease
shall be apportioned by the Board of Directors among the three classes of directors so as to ensure
that no one class has more than one director more than any other class. To the extent possible,
consistent with the foregoing rule, any newly created directorships shall be added to those classes
whose terms of office are to expire at the latest dates following such allocation, and any newly
eliminated directorships shall be subtracted from those classes whose terms of office are to expire
at the earliest dates following such allocation, unless otherwise provided from time to time by
resolution adopted by the Board of Directors.
SECTION 3.6 NOMINATIONS. (a) Notwithstanding anything in these Bylaws to the contrary, only
persons who are nominated in accordance with the procedures hereinafter set forth in this Section
3.6 shall be eligible for election as directors of the Corporation.
(b) Nominations of persons for election to the Board of Directors at a meeting of Stockholders
may be made only (i) by or at the direction of the Board of Directors or (ii) by any Stockholder
entitled to vote for the election of directors at the meeting who satisfies the eligibility
requirements (if any) set forth in the Certificate of Incorporation and who complies with the
notice procedures set forth in this Section 3.6 and in the Certificate of Incorporation; provided,
however, Stockholders may not nominate persons for election to the Board of Directors at any
special meeting of Stockholders unless the business to be transacted at such special meeting, as
set forth in the notice of such meeting, includes the election of directors. Nominations by
Stockholders shall be made pursuant to timely notice in writing to the Secretary. To be timely, a
Stockholders notice given in the context of an annual meeting of Stockholders shall be delivered
to or mailed and received at the principal executive office of the Corporation not less than 120
days nor more than 150 days in advance of the first anniversary of the date of the Corporations
proxy statement released to Stockholders in connection with the previous years annual meeting of
Stockholders; provided, however, that if no annual meeting was held in the previous year or the
date of the annual meeting of Stockholders has been changed by more than 30 calendar days from the
date contemplated at the time of the previous years proxy statement, the notice must be received
by the Corporation at least 80 days prior to the date the Corporation intends to distribute its
proxy statement with respect to such meeting. To be timely, a Stockholders notice given in the
context of a special meeting of Stockholders shall be delivered to or mailed and received at the
principal executive office of the Corporation not earlier than the ninetieth day prior to such
special meeting and not later than the close of business on the later of the seventieth day prior
to such special meeting or the tenth day following the day on which public announcement is first
made of the date of the special meeting and of the nominees proposed by the Board of Directors to
be elected at such special meeting. For purposes of the foregoing, public announcement means the
disclosure in a press release reported by the Dow Jones News Service, Associated Press or
comparable national news service, or in a document publicly filed by the Corporation with the
Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act. Any
meeting of Stockholders which is adjourned and will reconvene within 30 days after the meeting date
as originally noticed shall, for purposes of any notice contemplated by this paragraph (b), be
deemed to be a continuation of the original meeting and no nominations by a Stockholder of persons
to be elected directors of the Corporation may be made at any such reconvened meeting other than
pursuant to a notice that was timely for the meeting on the date originally noticed.
- 9 -
(c) Each notice given by a Stockholder as contemplated by paragraph (b) above shall set forth
the following information, in addition to any other information or matters required by the
Certificate of Incorporation:
(i) as to each person whom the Stockholder proposes to nominate for election or re-election as
a director, (A) the exact name of such person, (B) such persons age, principal occupation,
business address and telephone number and residence address and telephone number, (C) the number of
shares (if any) of each class of stock of the Corporation owned directly or indirectly by such
person and (D) all other information relating to such person that is required to be disclosed in
solicitations of proxies for election of directors pursuant to Regulation 14A under the Exchange
Act or any successor regulation thereto (including such persons notarized written acceptance of
such nomination, consent to being named in the proxy statement as a nominee and statement of
intention to serve as a director if elected);
(ii) as to the Stockholder giving the notice, (A) his name and address, as they appear on the
Corporations books, (B) his principal occupation, business address and telephone number and
residence address and telephone number, (C) the class and number of shares of the Corporation which
are held of record or beneficially owned by him and (D) the dates upon which he acquired such
shares of stock and documentary support for any claims of beneficial ownership; and
(iii) a description of all arrangements or understandings between the Stockholder giving the
notice and each nominee and any other person or persons (naming such person or persons) pursuant to
which the nomination or nominations are to be made by such Stockholder.
At the request of the Board of Directors, any person nominated by the Board of Directors for
election as a director shall furnish to the Secretary of the Corporation that information required
to be set forth in a Stockholders notice of nomination which pertains to the nominee.
(d) The foregoing right of a Stockholder to nominate a person for election or reelection to
the Board of Directors shall be subject to such conditions, restrictions and limitations as may be
imposed by the Certificate of Incorporation.
(e) Nothing in this Section 3.6 shall be deemed to affect any rights of Stockholders to
request inclusion of proposals in the Corporations proxy statement pursuant to Rule 14a-8 of the
Exchange Act.
(f) The chairman of a meeting of Stockholders shall have the power and duty to determine
whether a nomination was made in accordance with the procedures set forth in this Section 3.6 and,
if any nomination is not in compliance with this Section 3.6, to declare that such defective
nomination shall be disregarded.
SECTION 3.7 RESIGNATIONS. Any director may resign at any time by giving notice, either
written or by electronic communications, to the Board of Directors or the Secretary. Such
resignation shall take effect at the date of receipt of such notice or at any later time specified
therein. Acceptance of such resignation shall not be necessary to make it effective. When one or
more directors shall resign from the Board of Directors, effective at a future date, a majority of
the directors then in office, including those who have so resigned, shall
- 10 -
have the power to fill such vacancy or vacancies, the vote thereon to take effect when such
resignation or resignations shall become effective, and each director so chosen shall hold office
for the unexpired portion of the term of the director whose place shall be vacated and until his
successor shall have been duly elected and qualified.
SECTION 3.8 REMOVAL. No director may be removed before the expiration of his term of office
except for cause and then only by the affirmative vote of the holders of not less than a majority
of the voting power of all outstanding Voting Stock, voting together as a single class. The Board
of Directors may not remove any director, and no recommendation by the Board of Directors that a
director be removed may be made to the Stockholders unless such recommendation is set forth in a
resolution adopted by the affirmative vote of not less than 66-2/3% of the directors.
SECTION 3.9 VACANCIES. (a) In case any vacancy shall occur on the Board of Directors because
of death, resignation or removal, such vacancy may be filled by a majority of the directors
remaining in office (though less than a quorum) or by the sole remaining director. The director so
appointed shall serve for the unexpired term of his predecessor or until his successor is elected
and qualified or until his earlier death, resignation or removal. If there are no directors then
in office, an election of directors may be held in the manner provided by applicable law.
(b) Any newly-created directorship resulting from any increase in the number of authorized
directors may be filled by a majority of the directors then in office (though less than a quorum),
or by the sole remaining director. The director so appointed shall be assigned to such class of
directors as such majority of directors, or the sole remaining director, as the case may be, shall
determine; provided however, that newly-created directorships shall be apportioned among the
classes of directors so that all classes will be as nearly equal in number as possible. Each
director so appointed shall hold office until his successor is elected and qualified or until his
earlier death, resignation or removal.
(c) Except as expressly provided in these Bylaws or the Certificate of Incorporation or as
otherwise provided by law, Stockholders shall not have any right to fill vacancies on the Board of
Directors, including newly-created directorships.
(d) If, as a result of a disaster or emergency (as determined in good faith by the then
remaining directors), it becomes impossible to ascertain whether or not vacancies exist on the
Board of Directors, and a person is, or persons are, elected by the directors, who in good faith
believe themselves to be a majority of the remaining directors, or the sole remaining director, to
fill a vacancy or vacancies that such remaining directors in good faith believe exists, then the
acts of such person or persons who are so elected as directors shall be valid and binding upon the
Corporation and the Stockholders, although it may subsequently develop that at the time of the
election (i) there was in fact no vacancy or vacancies existing on the Board of Directors or (ii)
the directors, or the sole remaining director, who so elected such person or persons did not in
fact constitute a majority of the remaining directors.
SECTION 3.10 SUBJECT TO RIGHTS OF HOLDERS OF PREFERRED STOCK. Notwithstanding the foregoing
provisions of this Article III, if the resolutions of the Board of
- 11 -
Directors creating any series of preferred stock of the Corporation entitle the holders of
such preferred stock, voting separately by series, to elect additional directors under specified
circumstances, then all provisions of such resolutions relating to the nomination, election, term
of office, removal, filling of vacancies and other features of such directorships shall, as to such
directorships, govern and control over any conflicting provisions of this Article III.
SECTION 3.11 COMPENSATION. The Board of Directors shall have the authority to fix, and from
time to time to change, the compensation of directors. Each director shall be entitled to
reimbursement from the Corporation for his reasonable expenses incurred in attending meetings of
the Board of Directors (or any committee thereof) and meetings of the Stockholders. Nothing
contained in these Bylaws shall preclude any director from serving the Corporation in any other
capacity and receiving compensation therefor.
ARTICLE IV
BOARD OF DIRECTORS MEETINGS AND ACTIONS
SECTION 4.1 PLACE OF MEETINGS. The directors may hold their meetings and have one or more
offices, and keep the books of the Corporation, in such place or places, within or without the
State of Delaware, as the Board of Directors may from time to time determine.
SECTION 4.2 REGULAR MEETINGS. Regular meetings of the Board of Directors may be held without
notice at such time and place, within or without the State of Delaware, as shall from time to time
be determined by the Board of Directors. Except as otherwise provided by applicable law, any
business may be transacted at any regular meeting of the Board of Directors.
SECTION 4.3 SPECIAL MEETINGS. Special meetings of the Board of Directors shall be called by
the Secretary at the request of the Chairman of the Board (if any) or the Chief Executive Officer
on not less than 24 hours notice to each director, specifying the time, place and purpose of the
meeting. Special meetings shall be called by the Secretary on like notice at the request, in
writing or by electronic communication, of any two directors, which request shall state the purpose
of the meeting.
SECTION 4.4 QUORUM; VOTING. (a) At all meetings of the Board of Directors, a majority of the
directors shall be necessary and sufficient to constitute a quorum for the transaction of business.
If a quorum shall not be present at any meeting of the Board of Directors, the directors present
thereat may adjourn the meeting from time to time (without notice other than announcement at the
meeting) until a quorum shall be present. A meeting of the Board of Directors at which a quorum is
initially present may continue to transact business notwithstanding the withdrawal of directors;
provided, however, that no action of the remaining directors shall constitute the act of the Board
of Directors unless the action is approved by at least a majority of the required quorum for the
meeting or such greater number of directors as shall be required by applicable law, by the
Certificate of Incorporation or by these Bylaws.
(b) The act of a majority of the directors present at any meeting of the Board of Directors at
which there is a quorum shall be the act of the Board of Directors unless, by express provision
- 12 -
of law, the Certificate of Incorporation, or these Bylaws, a different vote is required, in
which case such express provision shall govern and control.
SECTION 4.5 CONDUCT OF MEETINGS. At meetings of the Board of Directors, business shall be
transacted in such order as shall be determined by the chairman of the meeting unless the Board of
Directors shall otherwise determine the order of business. The Board of Directors shall keep
regular minutes of its proceedings which shall be placed in the minute book of the Corporation.
SECTION 4.6 PRESUMPTION OF ASSENT. A director who is present at a meeting of the Board of
Directors at which action on any corporate matter is taken shall be presumed to have assented to
such action unless his dissent shall be entered in the minutes of the meeting or unless he shall
file his dissent, either in writing or by electronic communication, to such action with the person
acting as secretary of the meeting before the adjournment thereof or shall forward any dissent by
certified or registered mail to the Secretary immediately after the adjournment of the meeting.
Such right to dissent shall not apply to any director who voted in favor of such action.
SECTION 4.7 ACTION WITHOUT MEETING. Unless otherwise provided in the Certificate of
Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the
Board of Directors may be taken without a meeting if all directors consent thereto in writing. All
such written consents shall be filed with the minutes of proceedings of the Board of Directors.
SECTION 4.8 TELEPHONIC MEETINGS. Unless otherwise restricted by the Certificate of
Incorporation or these Bylaws, members of the Board of Directors may participate in a meeting of
the Board of Directors by means of conference telephone or similar communications equipment by
means of which all persons participating in the meeting can hear each other, and such participation
in a meeting shall constitute presence in person at such meeting.
ARTICLE V
COMMITTEES OF THE BOARD OF DIRECTORS
SECTION 5.1 EXECUTIVE COMMITTEE. (a) The Board of Directors may, by resolution adopted by
the affirmative vote of a majority of the directors, designate an Executive Committee which, during
the intervals between meetings of the Board of Directors and subject to Section 5.11, shall have
and may exercise, in such manner as it shall deem to be in the best interests of the Corporation,
all of the powers of the Board of Directors in the management or direction of the business and
affairs of the Corporation, except as reserved to the Board of Directors or as delegated by the
Board of Directors to another committee of the Board of Directors or as may be prohibited by law.
The Executive Committee shall consist of not less than two directors, the exact number to be
determined from time to time by the affirmative vote of a majority of the directors. None of the
members of the Executive Committee need be an officer of the Corporation.
- 13 -
(b) Meetings of the Executive Committee may be called at any time by the Chairman of the Board
(if any) or the Chief Executive Officer on not less than one days notice to each member given
verbally or in writing, which notice shall specify the time, place and purpose of the meeting.
SECTION 5.2 OTHER COMMITTEES. The board of directors may, by resolution adopted by a majority
of the directors, establish additional standing or special committees of the Board of Directors,
each of which shall consist of two or more directors (the exact number to be determined from time
to time by the Board of Directors) and, subject to Section 5.11, shall have such powers and
functions as may be delegated to it by the Board of Directors. No member of any such additional
committee need be an officer of the Corporation.
SECTION 5.3 TERM. Each member of a committee of the Board of Directors shall serve as such
until the earliest of (i) his death, (ii) the expiration of his term as a director, (iii) his
resignation as a member of such committee or as a director and (iv) his removal as a member of such
committee or as a director.
SECTION 5.4 COMMITTEE CHANGES; REMOVAL. The Board of Directors shall have the power at any
time to fill vacancies in, to change the membership of, and to abolish any committee of the Board
of Directors; provided, however, that no such action shall be taken in respect of the Executive
Committee unless approved by a majority of the directors.
SECTION 5.5 ALTERNATE MEMBERS. The Board of Directors may designate one or more directors as
alternate members of any committee, who may replace any absent or disqualified member at any
meeting of the committee. If no alternate members have been so appointed or each such alternate
committee member is absent or disqualified, the committee member or members thereof present at any
meeting and not disqualified from voting, whether or not he or they constitute a quorum, may
unanimously appoint another member of the Board of Directors to act at the meeting in the place of
any absent or disqualified member.
SECTION 5.6 RULES AND PROCEDURES. (a) The Board of Directors may designate one member of
each committee as chairman of such committee; provided, however, that, except as provided in the
following sentence, no person shall be designated as chairman of the Executive Committee unless
approved by a majority of the directors. If a chairman is not so designated for any committee, the
members thereof shall designate a chairman.
(b) Each committee shall adopt its own rules (not inconsistent with these Bylaws or with any
specific direction as to the conduct of its affairs as shall have been given by the Board of
Directors) governing the time, place and method of holding its meetings and the conduct of its
proceedings and shall meet as provided by such rules.
(c) If a committee is comprised of an odd number of members, a quorum shall consist of a
majority of that number. If a committee is comprised of an even number of members, a quorum shall
consist of one-half of that number. If a committee is comprised of two members, a quorum shall
consist of both members. If a quorum is not present at a meeting of any committee, a majority of
the members present may adjourn the meeting from time to time, without notice other than an
announcement at the meeting, until a quorum is present. The act of a majority of
- 14 -
the members present at any meeting at which a quorum is in attendance shall be the act of a
committee, unless the act of a greater number is required by law, the Certificate of Incorporation,
these Bylaws or the committees rules as adopted in Section 5.6(b).
(d) Each committee shall keep regular minutes of its meetings and report the same to the Board
of Directors when requested.
(e) Unless otherwise provided by these Bylaws or by the rules adopted by any committee, notice
of the time and place of each meeting of such committee shall be given to each member of such
committee as provided in these Bylaws with respect to notices of special meetings of the Board of
Directors.
SECTION 5.7 PRESUMPTION OF ASSENT. A member of a committee of the Board of Directors who is
present at a meeting of such committee at which action on any corporate matter is taken shall be
presumed to have assented to such action unless his dissent shall be entered in the minutes of the
meeting or unless he shall file his dissent, in writing or by electronic communication, to such
action with the person acting as secretary of the meeting before the adjournment thereof or shall
forward any dissent by certified or registered mail to the Secretary of the Corporation immediately
after the adjournment of the meeting. Such right to dissent shall not apply to any member who
voted in favor of such action.
SECTION 5.8 ACTION WITHOUT MEETING. Unless otherwise provided in the Certificate of
Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of a
committee of the Board of Directors may be taken without a meeting if all members of such committee
consent thereto in writing or by electronic communication. All such consents shall be filed with
the minutes of proceedings of such committee.
SECTION 5.9 TELEPHONIC MEETINGS. Unless otherwise restricted by the Certificate of
Incorporation or these Bylaws, members of any committee of the Board of Directors may participate
in a meeting of such committee by means of conference telephone or similar communications equipment
by means of which all persons participating in the meeting can hear each other, and such
participation in a meeting shall constitute presence in person at such meeting.
SECTION 5.10 RESIGNATIONS. Any committee member may resign at any time by giving notice, in
writing or by electronic communication, to the Board of Directors or the Secretary. Such
resignation shall take effect at the date of receipt of such notice or at any later time specified
therein. Acceptance of such resignation shall not be necessary to make it effective.
SECTION 5.11 LIMITATIONS ON AUTHORITY. Unless otherwise provided in the Certificate of
Incorporation, no committee of the Board of Directors shall have the power or authority to (i)
authorize an amendment to the Certificate of Incorporation, (ii) adopt an agreement of merger or
consolidation, recommend to the Stockholders the sale, lease or exchange of all or substantially
all of the Corporations property and assets, (iii) recommend to the Stockholders a dissolution of
the Corporation or a revocation of a dissolution, (iv) amend these Bylaws, (v) declare a dividend
or other distribution on, or authorize the issuance, purchase
- 15 -
or redemption of, securities of the Corporation, (vi) elect any officer of the Corporation or
(vii) approve any material transaction between the Corporation and one or more of its directors,
officers or employees or between the Corporation and any corporation, partnership, association or
other organization in which one or more of its directors, officers or employees are directors or
officers or have a financial interest; provided, however, that the Executive Committee may, to the
extent authorized in the resolution or resolutions providing for the issuance of shares of
preferred stock adopted by the Board of Directors as provided in the Certificate of Incorporation,
fix the designations and any of the preferences or rights of such shares relating to dividends,
redemption, dissolution, any distribution of assets of the Corporation or the conversion into, or
the exchange of such shares for, shares of any other class or classes of stock of the Corporation
or fix the number of shares of any series of stock or authorize the decrease or increase of the
shares of any such series.
ARTICLE VI
OFFICERS
SECTION 6.1 NUMBER; TITLES; QUALIFICATION; TERM OF OFFICE. (a) The officers of the
Corporation shall be a Chief Executive Officer, a President, a Chief Scientific Officer, a
Secretary and a Treasurer. The Board of Directors from time to time may also elect such other
officers (including, without limitation, a Chairman of the Board, Chief Financial Officer and one
or more Vice Presidents) as the Board of Directors deems appropriate or necessary. Each officer
shall hold office until his successor shall have been duly elected and shall have been qualified or
until his earlier death, resignation or removal. Any two or more offices may be held by the same
person, but no officer shall execute any instrument in more than one capacity if such instrument is
required by law or any act of the Corporation to be executed or countersigned by two or more
officers. None of the officers need be a Stockholder or a resident of the State of Delaware. No
officer (other than the Chairman of the Board, if any) need be a director.
(b) The Board of Directors may delegate to the Chairman of the Board (if any) and/or the Chief
Executive Officer the power to appoint one or more employees of the Corporation as divisional or
departmental vice presidents and fix their duties as such appointees. However, no such divisional
or departmental vice presidents shall be considered an officer of the Corporation, the officers of
the Corporation being limited to those officers elected by the Board of Directors.
SECTION 6.2 ELECTION. At the first meeting of the Board of Directors after each annual
meeting of Stockholders at which a quorum shall be present, the Board of Directors shall elect the
officers of the Corporation.
SECTION 6.3 REMOVAL. Any officer may be removed, either with or without cause, by the Board
of Directors; provided, however, that (i) the Chairman of the Board (if any) and the Chief
Executive Officer may be removed only by the affirmative vote of a majority of the directors and
(ii) the removal of any officer shall be without prejudice to the contract rights, if any, of such
officer. Election or appointment of an officer shall not of itself create contract rights.
- 16 -
SECTION 6.4 RESIGNATIONS. Any officer may resign at any time by giving notice, in writing or
by electronic communication, to the Board of Directors, the Chairman of the Board (if any) or the
Chief Executive Officer. Any such resignation shall take effect on receipt of such notice or at
any later time specified therein. Unless otherwise specified therein, the acceptance of such
resignation shall not be necessary to make it effective. Any such resignation is without prejudice
to the rights, if any, of the Corporation under any contract to which the officer is a party.
SECTION 6.5 VACANCIES. If a vacancy shall occur in any office because of death, resignation,
removal, disqualification or any other cause, the Board of Directors may elect or appoint a
successor to fill such vacancy for the remainder of the term.
SECTION 6.6 SALARIES. The salaries of all officers of the Corporation shall be fixed by the
Board of Directors or pursuant to its direction, and no officer shall be prevented from receiving
such salary by reason of the fact that he is also a director of the Corporation.
SECTION 6.7 CHAIRMAN OF THE BOARD. The Chairman of the Board (if any) shall have all powers
and shall perform all duties incident to the office of Chairman of the Board and such other powers
and duties as may be prescribed by the Board of Directors or these Bylaws. The Chairman of the
Board, if present, shall preside at all meetings of the Board of Directors and of the Stockholders.
During the time of any vacancy in the office of Chief Executive Officer or in the event of the
absence or disability of the Chief Executive Officer, the Chairman of the Board shall have the
duties and powers of the Chief Executive Officer unless otherwise determined by the Board of
Directors. In no event shall any third party having dealings with the Corporation be bound to
inquire as to any facts required by the terms of this Section 6.7 for the exercise by the Chairman
of the Board of the powers of the Chief Executive Officer.
SECTION 6.8 CHIEF EXECUTIVE OFFICER. (a) The Chief Executive Officer shall be the chief
executive officer of the Corporation and, subject to the supervision, direction and control of the
Board of Directors, shall have general supervision, direction and control of the business and
officers of the Corporation with all such powers as may be reasonably incident to such
responsibilities. He shall have the general powers and duties of management usually vested in the
chief executive officer of a corporation.
(b) During the time of any vacancy in the office of the Chairman of the Board or in the event
of the absence or disability of the Chairman of the Board, the Chief Executive Officer shall have
the duties and powers of the Chairman of the Board unless otherwise determined by the Board of
Directors. During the time of any vacancy in the office of President or in the event of the
absence or disability of the President, the Chief Executive Officer shall have the duties and
powers of the President unless otherwise determined by the Board of Directors. In no event shall
any third party having any dealings with the Corporation be bound to inquire as to any facts
required by the terms of this Section 6.8 for the exercise by the Chief Executive Officer of the
powers of the Chairman of the Board or the President.
SECTION 6.9 PRESIDENT. (a) The President shall be the chief operating officer of the
Corporation and, subject to the supervision, direction and control of the Chief Executive
- 17 -
Officer and the Board of Directors, shall manage the day-to-day operations of the Corporation.
He shall have the general powers and duties of management usually vested in the chief operating
officer of a corporation and such other powers and duties as may be assigned to him by the Board of
Directors, the Chief Executive Officer or these Bylaws.
(b) During the time of any vacancy in the offices of the Chairman of the Board and Chief
Executive Officer or in the event of the absence or disability of the Chairman of the Board and the
Chief Executive Officer, the President shall have the duties and powers of the Chief Executive
Officer unless otherwise determined by the Board of Directors. In no event shall any third party
having any dealings with the Corporation be bound to inquire as to any facts required by the terms
of this Section 6.9 for the exercise by the President of the powers the Chief Executive Officer.
SECTION 6.10 CHIEF SCIENTIFIC OFFICER. The Chief Scientific Officer shall be the chief
scientific officer of the Corporation and, subject to the supervision, direction and control of the
Board of Directors and President, shall have general supervision, direction and control of the
Corporations scientific endeavors with all such powers as may be reasonably incident to such
responsibilities. He shall have the general powers and duties of management usually vested in the
chief scientific officer of a corporation.
SECTION 6.11 VICE PRESIDENTS. In the absence or disability of the President, the Vice
Presidents, if any, in order of their rank as fixed by the Board of Directors, or if not ranked,
the Vice President designated by the President, shall perform all the duties of the President as
chief operating officer of the Corporation, and when so acting shall have all the powers of, and be
subject to all the restrictions upon, the President as chief operating officer of the Corporation.
In no event shall any third party having dealings with the Corporation be bound to inquire as to
any facts required by the terms of this Section 6.11 for the exercise by any Vice President of the
powers of the President as chief operating officer of the Corporation. The Vice Presidents shall
have such other powers and perform such other duties as from time to time may be assigned to them
by the Board of Directors, the Chief Executive Officer or the President.
SECTION 6.12 TREASURER. The Treasurer shall (i) have custody of the Corporations funds and
securities, (ii) keep full and accurate account of receipts and disbursements, (iii) deposit all
monies and valuable effects in the name and to the credit of the Corporation in such depository or
depositories as may be designated by the Board of Directors and (iv) perform such other duties as
may be prescribed by the Board of Directors or the Chief Executive Officer.
SECTION 6.13 ASSISTANT TREASURERS. Each Assistant Treasurer shall have such powers and duties
as may be assigned to him by the Board of Directors, the Chief Executive Officer or the President.
In case of the absence or disability of the Treasurer, the Assistant Treasurer designated by the
President (or, in the absence of such designation, the Treasurer) shall perform the duties and
exercise the powers of the Treasurer during the period of such absence or disability. In no event
shall any third party having dealings with the Corporation be bound to inquire as to any facts
required by the terms of this Section 6.13 for the exercise by any Assistant Treasurer of the
powers of the Treasurer under these Bylaws.
- 18 -
SECTION 6.14 SECRETARY. (a) The Secretary shall keep or cause to be kept, at the principal
office of the Corporation or such other place as the Board of Directors may order, a book of
minutes of all meetings and actions of the Board of Directors, committees of the Board of Directors
and Stockholders, with the time and place of holding, whether regular or special, and, if special,
how authorized, the notice thereof given, the names of those present at meetings of the Board of
Directors and committees thereof, the number of shares present or represented at Stockholders
meetings and the proceedings thereof.
(b) The Secretary shall keep, or cause to be kept, at the principal office of the Corporation
or at the office of the Corporations transfer agent or registrar, a share register, or a duplicate
share register, showing the names of all Stockholders and their addresses, the number and classes
of shares held by each, the number and date of certificates issued for the same and the number and
date of cancellation of every certificate surrendered for cancellation.
(c) The Secretary shall give, or cause to be given, notice of all meetings of the Stockholders
and of the Board of Directors required by these Bylaws or by law to be given, and he shall keep the
seal of the Corporation, if one be adopted, in safe custody, and shall have such other powers and
perform such other duties as may be prescribed by the Board of Directors, the Chairman of the Board
(if any), the Chief Executive Officer, the President or these Bylaws.
(d) The Secretary may affix the seal of the Corporation, if one be adopted, to contracts of
the Corporation.
SECTION 6.15 ASSISTANT SECRETARIES. Each Assistant Secretary shall have such powers and
duties as may be assigned to him by the Board of Directors, the Chairman of the Board (if any), the
Chief Executive Officer or the President. In case of the absence or disability of the Secretary,
the Assistant Secretary designated by the President (or, in the absence of such designation, the
Secretary) shall perform the duties and exercise the powers of the Secretary during the period of
such absence or disability. In no event shall any third party having dealings with the Corporation
be bound to inquire as to any facts required by the terms of this Section 6.15 for the exercise by
any Assistant Secretary of the powers of the Secretary under these Bylaws.
ARTICLE VII
STOCK
SECTION 7.1 CERTIFICATES. Certificates for shares of stock of the Corporation shall be in
such form as shall be approved by the Board of Directors. The certificates shall be signed (i) by
the Chairman of the Board (if any), the Chief Executive Officer, the President or a Vice President
and (ii) by the Secretary, an Assistant Secretary, the Treasurer or an Assistant Treasurer.
SECTION 7.2 SIGNATURES ON CERTIFICATES. Any or all of the signatures on the certificates may
be a facsimile and the seal of the Corporation (or a facsimile thereof), if one has been adopted,
may be affixed thereto. In case any officer, transfer agent or registrar who has signed, or whose
facsimile signature has been placed upon, a certificate shall have ceased to be
- 19 -
such officer, transfer agent or registrar before such certificate is issued, such certificate
may be issued by the Corporation with the same effect as if he were such officer, transfer agent or
registrar at the date of issue.
SECTION 7.3 LEGENDS. The Board of Directors shall have the power and authority to provide
that certificates representing shares of stock of the Corporation bear such legends and statements
(including, without limitation, statements relating to the powers, designations, preferences and
relative, participating, optional or other special rights and qualifications, limitations or
restrictions of the shares represented by such certificates) as the Board of Directors deems
appropriate in connection with the requirements of federal or state securities laws or other
applicable laws.
SECTION 7.4 LOST, STOLEN OR DESTROYED CERTIFICATES. The Board of Directors, the Secretary and
the Treasurer each may direct a new certificate or certificates to be issued in place of any
certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen
or destroyed, in each case upon the making of an affidavit of that fact by the owner of such
certificate, or his legal representative. When authorizing such issue of a new certificate or
certificates, the Board of Directors, the Secretary or the Treasurer, as the case may be, may, in
its or his discretion and as a condition precedent to the issuance thereof, require the owner of
such lost, stolen or destroyed certificate or certificates, or his legal representative, to
advertise the same in such manner as the Board of Directors, the Secretary or the Treasurer, as the
case may be, shall require and/or to furnish the Corporation a bond in such form and substance and
with such surety as the Board of Directors, the Secretary or the Treasurer, as the case may be, may
direct as indemnity against any claim, or expense resulting from any claim, that may be made
against the Corporation with respect to the certificate alleged to have been lost, stolen or
destroyed.
SECTION 7.5 TRANSFERS OF SHARES. Shares of stock of the Corporation shall be transferable
only on the books of the Corporation by the holders thereof in person or by their duly authorized
attorneys or legal representatives. Upon surrender to the Corporation, or the transfer agent of
the Corporation, of a certificate for shares duly endorsed or accompanied by proper evidence of
succession, assignment or authority to transfer, the Corporation or its transfer agent shall issue
a new certificate to the person entitled thereto, cancel the old certificate and record the
transaction upon the Corporations books. Notwithstanding the foregoing, the Corporation will not
register (and will instruct its transfer agent or registrar not to register) any transfer of shares
of stock of the Corporation which are issued or sold pursuant to Regulation S under the Securities
Act of 1933, as amended (the Securities Act) unless such transfer is made in accordance with the
provisions of Regulation S, pursuant to registration under the Securities Act or pursuant to an
available exemption from registration under the Securities Act. The Board of Directors may from
time to time determine whether a transfer of shares of stock of the Corporation is made in
accordance with the provisions of Regulation S, pursuant to registration under the Securities Act
or pursuant to an available exemption from registration under the Securities Act. In making its
determination, the Board of Directors of the Corporation may require such opinions of counsel,
affidavits, undertakings or agreements as it may deem necessary or advisable.
- 20 -
SECTION 7.6 REGISTERED STOCKHOLDERS. The Corporation shall be entitled to treat the holder of
record of any share of stock of the Corporation as the holder in fact thereof and, accordingly,
shall not be bound to recognize any equitable or other claim or interest in such share on the part
of any other person, whether or not the Corporation shall have express or other notice thereof,
except as expressly provided by the laws of the State of Delaware.
SECTION 7.7 REGULATIONS. The Board of Directors shall have the power and authority to make
all such rules and regulations as they may deem expedient concerning the issue, transfer and
registration or the replacement of certificates for shares of stock of the Corporation. The Board
of Directors may (i) appoint and remove transfer agents and registrars of transfers and (ii)
require all stock certificates to bear the signature of any such transfer agent and/or any such
registrar of transfers.
SECTION 7.8 STOCK OPTIONS, WARRANTS, ETC. Unless otherwise expressly prohibited in the
resolutions of the Board of Directors creating any class or series of preferred stock of the
Corporation, the Board of Directors shall have the power and authority to create and issue (whether
or not in connection with the issue and sale of any stock or other securities of the Corporation)
warrants, rights or options entitling the holders thereof to purchase from the Corporation any
shares of capital stock of the Corporation of any class or series or any other securities of the
Corporation for such consideration and to such persons, firms or corporations as the Board of
Directors, in its sole discretion, may determine, setting aside from the authorized but unissued
stock of the Corporation the requisite number of shares for issuance upon the exercise of such
warrants, rights or options. Such warrants, rights and options shall be evidenced by one or more
instruments approved by the Board of Directors. The Board of Directors shall be empowered to set
the exercise price, duration, time for exercise and other terms of such warrants, rights and
operations; provided, however, that the consideration to be received for any shares of capital
stock subject thereto shall not be less than the par value thereof.
ARTICLE VIII
INDEMNIFICATION
SECTION 8.1 THIRD PARTY ACTIONS. The Corporation (i) shall, to the maximum extent permitted
from time to time under the laws of the State of Delaware, indemnify every person who is or was a
party or is or was threatened to be made a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative (other than an action
by or in the right of the Corporation), by reason of the fact that such person is or was a director
or officer of the Corporation or any of its direct or indirect subsidiaries or is or was serving at
the request of the Corporation or any of its direct or indirect subsidiaries as a director, officer
or fiduciary of another corporation, partnership, joint venture, trust, employee benefit plan or
other enterprise, and (ii) may, to the maximum extent permitted from time to time under the laws of
the State of Delaware, indemnify every person who is or was a party or is or was threatened to be
made a party to any threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in the right of the
Corporation), by reason of the fact that such person is or was an employee or agent of the
Corporation or any of its direct or indirect subsidiaries or is or was
- 21 -
serving at the request of the Corporation or any of its direct or indirect subsidiaries as an
employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan
or other enterprise, against expenses (including counsel fees), judgments, fines and amounts paid
or owed in settlement, actually and reasonably incurred by such person or rendered or levied
against such person in connection with such action, suit or proceeding, if such person acted in
good faith and in a manner such person reasonably believed to be in or not opposed to the best
interests of the Corporation and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful. The termination of any action, suit or
proceeding by judgment, order, settlement, conviction or upon a plea of
nolo contendere
or its
equivalent shall not, in itself, create a presumption that the person did not act in good faith and
in a manner which such person reasonably believed to be in or not opposed to the best interests of
the Corporation or, with respect to any criminal action or proceeding, that the person had
reasonable cause to believe that his conduct was unlawful. Any person seeking indemnification
under this Section 8.1 shall be deemed to have met the standard of conduct required for such
indemnification unless the contrary is established.
SECTION 8.2 ACTIONS BY OR IN THE RIGHT OF THE CORPORATION. The Corporation (i) shall, to the
maximum extent permitted from time to time under the laws of the State of Delaware, indemnify every
person who is or was a party or who is or was threatened to be made a party to any threatened,
pending or completed action or suit by or in the right of the Corporation to procure a judgment in
its favor by reason of the fact that such person is or was a director or officer of the Corporation
or any of its direct or indirect subsidiaries or is or was serving at the request of the
Corporation or any of its direct or indirect subsidiaries as a director, officer or fiduciary of
another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise,
and (ii) may, to the maximum extent permitted from time to time under the laws of the State of
Delaware, indemnify every person who is or was a party or who is or was threatened to be made a
party to any threatened, pending or completed action or suit by or in the right of the Corporation
to procure a judgment in its favor by reason of the fact that such person is or was an employee or
agent of the Corporation or any of its direct or indirect subsidiaries or is or was serving at the
request of the Corporation or any of its direct or indirect subsidiaries as an employee or agent of
another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise,
against expenses (including counsel fees) actually and reasonably incurred by such person in
connection with the defense or settlement or such action or suit if such person acted in good faith
and in a manner such person reasonably believed to be in or not opposed to the best interests of
the Corporation; provided, however, that no indemnification shall be made with respect to any
claim, issue or matter as to which such person shall have been adjudged to be liable to the
Corporation unless and only to the extent that, despite the adjudication of liability but in view
of all the circumstances of the case, such person is fairly and reasonably entitled to
indemnification.
SECTION 8.3 EXPENSES. Expenses incurred by a director or officer of the Corporation or any of
its direct or indirect subsidiaries in defending a civil or criminal action, suit or proceeding
shall be paid by the Corporation in advance of the final disposition of such action, suit or
proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such
amount if it shall ultimately be determined that he is not entitled to be indemnified by the
Corporation as authorized in this Article VIII. Such expenses incurred by other employees and
agents of the Corporation and other persons eligible for indemnification
- 22 -
under this Article VIII may be paid upon such terms and conditions, if any, as the Board of
Directors deems appropriate.
SECTION 8.4 NON-EXCLUSIVITY. The indemnification and advancement of expenses provided by, or
granted pursuant to, this Article VIII shall not be deemed exclusive of any other rights to which
those seeking indemnification or advancement of expenses may be entitled under any provision of
law, the Certificate of Incorporation, the certificate of incorporation or bylaws or other
governing documents of any direct or indirect subsidiary of the Corporation, under any agreement,
vote of Stockholders or disinterested directors or under any policy or policies of insurance
maintained by the Corporation on behalf of any person or otherwise, both as to action in his
official capacity and as to action in another capacity while holding any of the positions or having
any of the relationships referred to in this Article VIII.
SECTION 8.5 ENFORCEABILITY. The provisions of this Article VIII (i) are for the benefit of,
and may be enforced directly by, each director or officer of the Corporation the same as if set
forth in their entirety in a written instrument executed and delivered by the Corporation and such
director or officer and (ii) constitute a continuing offer to all present and future directors and
officers of the Corporation. The Corporation, by its adoption of these Bylaws, (A) acknowledges
and agrees that each present and future director and officer of the Corporation has relied upon and
will continue to rely upon the provisions of this Article VIII in becoming, and serving as, a
director or officer of the Corporation or, if requested by the Corporation, a director, officer or
fiduciary or the like of another corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise, (B) waives reliance upon, and all notices of acceptance of, such
provisions by such directors and officers and (C) acknowledges and agrees that no present or future
director or officer of the Corporation shall be prejudiced in his right to enforce directly the
provisions of this Article VIII in accordance with their terms by any act or failure to act on the
part of the Corporation.
SECTION 8.6 INSURANCE. The Board of Directors may authorize, by a vote of the majority of the
directors, the Corporation to purchase and maintain insurance on behalf of any person who is or was
a director, officer, employee or agent of the Corporation, or is or was serving at the request of
the Corporation as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against any liability asserted against him and incurred by
him in any such capacity, or arising out of his status as such, whether or not the Corporation
would have the power to indemnify him against such liability under the provisions of this Article
VIII.
SECTION 8.7 SURVIVAL. The provisions of this Article VIII shall continue as to any person who
has ceased to be a director or officer of the Corporation and shall inure to the benefit of the
estate, executors, administrators, heirs, legatees and devisees of any person entitled to
indemnification under this Article VIII.
SECTION 8.8 AMENDMENT. No amendment, modification or repeal of this Article VIII or any
provision hereof shall in any manner terminate, reduce or impair the right of any past, present or
future director or officer of the Corporation to be indemnified by the Corporation, nor the
obligation of the Corporation to indemnify any such director or officer, under and in accordance
with the provisions of this Article VIII as in effect immediately prior to
- 23 -
such amendment, modification or repeal with respect to claims arising, in whole or in part,
from a state of facts extant on the date of, or relating to matters occurring prior to, such
amendment, modification or repeal, regardless of when such claims may arise or be asserted.
SECTION 8.9 DEFINITIONS. For purposes of this Article VIII, (i) reference to any person shall
include the estate, executors, administrators, heirs, legatees and devisees of such person, (ii)
employee benefit plan and fiduciary shall be deemed to include, but not be limited to, the
meaning set forth in Section 1002, subsections 3(3) and 21(A), respectively, of the Employee
Retirement Income Security Act of 1974, as amended, (iii) references to the judgments, fines and
amounts paid or owed in settlement or rendered or levied shall be deemed to encompass and include
excise taxes required to be paid pursuant to applicable law in respect of any transaction involving
an employee benefit plan and (iv) references to the Corporation shall be deemed to include any
predecessor corporation or entity and any constituent corporation or entity absorbed in a merger,
consolidation or other reorganization of or by the Corporation which, if its separate existence had
continued, would have had power and authority to indemnify its directors, officers, employees,
agents and fiduciaries so that any person who was a director, officer, employee, agent or fiduciary
of such predecessor or constituent corporation or entity, or served at the request of such
predecessor or constituent corporation or entity as a director, officer, employee, agent or
fiduciary of another corporation, partnership, joint venture, trust, employee benefit plan or other
enterprise, shall stand in the same position under the provisions of this Article VIII with respect
to the Corporation as such person would have with respect to such predecessor or constituent
corporation or entity if its separate existence had continued.
ARTICLE IX
NOTICES AND WAIVERS
SECTION 9.1 METHODS OF GIVING NOTICES. Whenever, by applicable law, the Certificate of
Incorporation or these Bylaws, notice is required to be given to any Stockholder, any director or
any member of a committee of the Board of Directors and no provision is made as to how such notice
shall be given, personal notice shall not be required and such notice may be given (i) in writing,
by mail, postage prepaid, addressed to such Stockholder, director or committee member at his
address as it appears on the books or (in the case of a Stockholder) the stock transfer records of
the Corporation or (ii) by any other method permitted by law (including, but not limited to,
overnight courier service, telegram, telex or telecopier). Any notice required or permitted to be
given by mail shall be deemed to be delivered and given at the time when the same is deposited in
the United States mail as aforesaid. Any notice required or permitted to be given by overnight
courier service shall be deemed to be delivered and given one business day after delivery to such
service with all charges prepaid and addressed as aforesaid. Any notice required or permitted to
be given by telegram, telex or telecopy shall be deemed to be delivered and given at the time
transmitted with all charges prepaid and addressed as aforesaid.
SECTION 9.2 WAIVER OF NOTICE. Whenever any notice is required to be given to any Stockholder,
director or member of a committee of the Board of Directors by applicable law, the Certificate of
Incorporation, or these Bylaws, a waiver thereof in writing signed by the person or persons
entitled to said notice, whether before or after the time stated therein, shall be
- 24 -
equivalent to the giving of such notice. Attendance of a Stockholder (whether in person or by
proxy), director or committee member at a meeting shall constitute a waiver of notice of such
meeting, except where such person attends for the express purpose of objecting to the transaction
of any business on the ground that the meeting is not lawfully called or convened.
ARTICLE X
BENEFICIAL OWNERSHIP NOTICES
SECTION 10.1 OWNERSHIP NOTICE. (a) Without prejudice to, and in addition to any other
obligation to disclose stockholder ownership interests under applicable law, where a Stockholder
either (i) to such Stockholders knowledge acquires an aggregate nominal value of a class or series
of the Corporations shares of stock in which such Stockholders interest is equal to or more than
3% of the aggregate outstanding shares of that class of shares (a Notifiable Interest); (ii)
ceases to have a Notifiable Interest; or (iii) becomes aware that such Stockholder has acquired a
Notifiable Interest, or that such Stockholder has ceased to have a Notifiable Interest in which
such Stockholder was previously interested, such Stockholder shall notify the Corporation in
writing of such Stockholders interest.
(b) Stockholders shall also notify the Corporation promptly following any increase or decrease
in the percentage level of such Stockholders Notifiable Interest. Only percentage level changes
equal to at least a whole number are required to be notified to the Corporation.
(c) Any notification under this Section 10.1 shall identify the Stockholder so interested, the
nature and extent of such Stockholders interest, and the date on which such Stockholder acquired
or ceased to hold a Notifiable Interest or on which there was an increase or decrease in the
percentage level of such Stockholders Notifiable Interest.
SECTION 10.2 DISCLOSURE NOTICE. The Board of Directors may serve a disclosure notice
(Disclosure Notice) in writing on any Stockholder whom the Board of Directors knows, or has
reasonable cause to believe, to hold a Notifiable Interest, requiring such Stockholder to indicate
in writing whether or not such Stockholder holds a Notifiable Interest and to provide the Board of
Directors written information concerning such Stockholders beneficial ownership of and voting
rights and powers of the shares of the Corporations stock held by such Stockholder.
SECTION 10.3 EFFECT OF DISCLOSURE NOTICE. (a) If a Disclosure Notice has been served on a
Stockholder and the Corporation has not received the information required in respect of the
specified shares in writing within a period of fourteen days after the service of the Disclosure
Notice, then the Board of Directors may determine to apply one or more of the following
restrictions (the Restrictions):
(i) the person holding the shares of the Corporations stock in the share register of the
Corporation which comprises or includes the shares in relation to which the default occurred (all
of the relevant number, as appropriate, of such shares being the Default Shares, which definition
shall include any further shares of capital stock which are issued in respect of such shares and
any other shares of capital stock of the Corporation held by such Stockholder) shall
- 25 -
not (for so long as the default occurs), nor shall any transferee to whom any of such shares
are transferred, be entitled to be present or to vote (either personally, or by proxy or otherwise)
at an annual or special meeting or at a separate meeting of the holders of a class or series of
shares, or to exercise any other right in relation to an annual or special meeting or a separate
class meeting;
(ii) no transfer the Default Shares shall be effective or shall be recognized by the
Corporation; and
(iii) no dividends or other sums which would otherwise be payable on or in respect of the
Default Shares shall be paid to such Stockholder holding the Default Shares and, in circumstances
where an offer of the right to elect to receive shares instead of cash in respect of a dividend is
or has been made, an election made in respect of the Default Shares shall not be effective.
(b) The Board of Directors may determine that one or more Restrictions imposed on Default
Shares shall cease to apply at any time. If the Corporation receives the information required in
the relevant Disclosure Notice, the Board of Directors shall, within seven days of receipt,
determine that all Restrictions imposed on the Default Shares shall cease to apply. In addition,
the Board of Directors may determine that all Restrictions imposed on the Default Shares shall
cease to apply if the Corporation receives an executed and, if necessary, duly stamped instrument
of transfer in respect of the Default Shares, which would otherwise be given effect to, by:
(i) a sale of the Default Shares on the AIM market;
(ii) acceptance of an offer to acquire all the shares of any class or series or classes or
series in the Corporation (other than shares which at the date of the offer are already sold by the
offeror), being an offer on terms which are the same in relation to all the shares to which the
offer relates or, where such shares include shares of different classes, in relation to all the
shares of each class; or
(iii) a sale which is shown to the satisfaction of the Board of Directors to be a bona fide
sale of the whole of the beneficial interest in the Default Shares to a person who is unconnected
with the person or with another person appearing to be interested in the shares.
(c) Where dividends or other sums payable on Default Shares are not paid as a result of
Restrictions having been imposed, the dividends or other sums shall accrue and be payable (without
interest) once the relevant Restrictions cease to apply to such Stockholder.
(d) If the Board of Directors makes a determination as described in Section 10.3(b) above it
shall notify the purported transferee as soon as practicable and any person may make
representations in writing to the Board of Directors concerning the determination. Neither the
Corporation nor the Board of Directors shall in any event be liable to any person as a result of
the Board of Directors having imposed Restrictions, or failed to determine that Restrictions shall
cease to apply, where the Board of Directors has acted in good faith.
- 26 -
ARTICLE XI
MISCELLANEOUS PROVISIONS
SECTION 11.1 DIVIDENDS. Subject to applicable law and the provisions of the Certificate of
Incorporation, dividends may be declared by the Board of Directors at any meeting and may be paid
in cash, in property or in shares of the Corporations capital stock. Any such declaration shall
be at the discretion of the Board of Directors. A director shall be fully protected in relying in
good faith upon the books of account of the Corporation or statements prepared by any of its
officers as to the value and amount of the assets, liabilities or net profits of the Corporation or
any other facts pertinent to the existence and amount of surplus or other funds from which
dividends might properly be declared.
SECTION 11.2 RESERVES. There may be created by the Board of Directors, out of funds of the
Corporation legally available therefor, such reserve or reserves as the Board of Directors from
time to time, in its absolute discretion, considers proper to provide for contingencies, to
equalize dividends or to repair or maintain any property of the Corporation, or for such other
purpose as the Board of Directors shall consider beneficial to the Corporation, and the Board of
Directors may thereafter modify or abolish any such reserve in its absolute discretion.
SECTION 11.3 CHECKS. All checks, drafts or other orders for payment of money, notes or other
evidences of indebtedness, issued in the name of or payable to the Corporation shall be signed by
such officer or officers or by such employees or agents of the Corporation as may be designated
from time to time by the Board of Directors.
SECTION 11.4 CORPORATE CONTRACTS AND INSTRUMENTS. Subject always to the specific directions
of the Board of Directors, the Chairman of the Board (if any), the President, any Vice President,
the Secretary or the Treasurer may enter into contracts and execute instruments in the name and on
behalf of the Corporation. The Board of Directors and, subject to the specific directions of the
Board of Directors, the Chairman of the Board (if any) or the President may authorize one or more
officers, employees or agents of the Corporation to enter into any contract or execute any
instrument in the name of and on behalf of the Corporation, and such authority may be general or
confined to specific instances.
SECTION 11.5 ATTESTATION. With respect to any deed, deed of trust, mortgage or other
instrument executed by the Corporation through its duly authorized officer or officers, the
attestation to such execution by the Secretary or an Assistant Secretary of the Corporation shall
not be necessary to constitute such deed, deed of trust, mortgage or other instrument a valid and
binding obligation of the Corporation unless the resolutions, if any, of the Board of Directors
authorizing such execution expressly state that such attestation is necessary.
SECTION 11.6 SECURITIES OF OTHER CORPORATIONS. The Chairman of the Board, the Chief Executive
Officer, the President or any Vice President of the Corporation shall have the power and authority
to transfer, endorse for transfer, vote, consent or take any other action with respect to any
securities of another issuer which may be held or owned by the
- 27 -
Corporation and to make, execute and deliver any waiver, proxy or consent with respect to any
such securities.
SECTION 11.7 FISCAL YEAR. The fiscal year of the Corporation shall be January 1 through
December 31, unless otherwise fixed by the Board of Directors.
SECTION 11.8 SEAL. The seal of the Corporation, if any, shall be such as from time to time
may be approved by the Board of Directors.
SECTION 11.9 INVALID PROVISIONS. If any part of these Bylaws shall be invalid or inoperative
for any reason, the remaining parts, so far as is possible and reasonable, shall remain valid and
operative.
SECTION 11.10 HEADINGS. The headings used in these Bylaws have been inserted for
administrative convenience only and shall not limit or otherwise affect any of the provisions of
these Bylaws.
SECTION 11.11 REFERENCES/GENDER/NUMBER. Whenever in these Bylaws the singular number is used,
the same shall include the plural where appropriate. Words of any gender used in these Bylaws
shall include the other gender where appropriate. In these Bylaws, unless a contrary intention
appears, all references to Articles and Sections shall be deemed to be references to the Articles
and Sections of these Bylaws.
SECTION 11.12 AMENDMENTS. These Bylaws may be altered, amended or repealed or new bylaws may
be adopted by the affirmative vote of a majority of the directors; provided, however, that no such
action shall be taken at any special meeting of the Board of Directors unless notice of such action
is contained in the notice of such special meeting. These Bylaws may not be altered, amended or
rescinded, nor may new bylaws be adopted, by the Stockholders except by the affirmative vote of the
holders of not less than 66-2/3% of the voting power of all outstanding Voting Stock, voting
together as a single class. Each alteration, amendment or repeal of these Bylaws shall be subject
in all respects to Section 8.7.
CERTIFICATE OF SECRETARY
I, Alton L. Boynton, the duly appointed Secretary of Northwest Biotherapeutics, Inc., hereby
certify that the foregoing Bylaws constitute the bylaws of Northwest Biotherapeutics, Inc. as
adopted by the Board of Directors on June 15, 2007 to be effective as of June 22, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
Alton L. Boynton, Secretary
|
|
|
- 28 -
EXHIBIT
10.1
CONVERSION AGREEMENT
This
Conversion Agreement
(this
Agreement
), is made and entered into as of June 15,
2007 by and among
Northwest Biotherapeutics, Inc.
, a Delaware corporation (the
Company
),
Toucan Capital Fund II, L.P.
,
a Delaware limited partnership
(
T
oucan Capital
)
and
Toucan Partners, LLC
,
a Delaware limited liability company (
Toucan Partners
).
Recitals
A.
Toucan Capital holds 32,500,000 shares of Series A Cumulative Convertible Preferred Stock
(the
Series A Preferred Stock
), which have the voting powers, designations, preferences,
protective provisions and other special rights, and qualifications, limitations and restrictions
thereof set forth in the Certificate of Designations, Preferences and Rights of Series A Cumulative
Convertible Preferred Stock (the
Certificate of Designations of Series A Preferred Stock
) of the
Company. Toucan Capital also holds 4,816,863 shares of Series A-1 Cumulative Convertible Preferred
Stock (the
Series A-1 Preferred Stock
and, together with the Series A Preferred Stock, the
Preferred Stock
), which have the voting powers, designations, preferences, protective provisions
and other special rights, and qualifications, limitations and restrictions thereof set forth in the
Certificate of Designations, Preferences and Rights of Series A-1 Cumulative Preferred Stock (the
Certificate of Designations of Series A-1 Preferred Stock
and, together with the Certificate of
Designations of Series A Preferred Stock, the
Certificates of Designation
) of the Company.
B
. The Company desires to have Toucan relinquish the preferences, protective provisions and
other special rights relating to the Series A and Series A-1 Preferred Stock, and the Company
recognizes that such preferences, protective provisions and other special rights have substantial
economic value.
C.
Toucan is willing to accommodate the Companys desire by converting its Series A and
Series A-1 Preferred Stock into Common Stock, conditional upon the terms and conditions set forth
herein, including, without limitation, the completion by the Company of a sale and issuance of
Common Stock on the London AIM market totaling at least £10 million, no later than June 22, 2007,
and Toucan Capital is providing written notice, contemplated by Section 5(D) of the Certificates of
Designations, to the Company of such conversion by virtue of this Agreement.
D
. Toucan Capital and the Company desire to enter into an agreement with respect to the
satisfaction of accrued and unpaid dividends on the Preferred Stock as of the time of the
conversion of the Preferred Stock into Common Stock, subject to the terms and conditions set forth
below.
E.
In consideration for (i) Toucan Capitals voluntary conversion of the Preferred Stock
(excluding any accrued and unpaid dividends) into Common Stock as evidenced hereby, (ii) Toucan
Capitals voluntary elimination of a number of rights, preferences and protections associated with
the Series A Preferred Stock and the Series A-1 Preferred Stock, including, without limitation, the
liquidation preference entitling Toucan Capital to certain substantial cash payments, (iii) Toucan
Capitals voluntary agreement to amend its Warrants for Series A and Series A-1 Preferred Stock to
provide that such Warrants shall cease to be exercisable for Series
A or Series A-1 Preferred Stock
and shall be exercisable only for Common Stock, (iv) Toucan Partners voluntary agreement to amend
certain notes and warrants to eliminate Toucan Partners existing rights to receive Series A-1
Preferred Stock under such notes and warrants, and provide that Toucan Partners shall receive
Common Stock in lieu of Series A-1 Preferred Stock under such notes and warrants; (v) Toucan
Partners voluntary elimination of a number of rights, preferences and protections associated with
the Series A-1 Preferred Stock, including, without limitation, the liquidation preference entitling
Toucan Partners to certain substantial cash payments, the Company is agreeing to issue additional
shares of Common Stock to Toucan Capital and Toucan Partners upon conversion of the Preferred Stock
described herein and execution of the amendments described herein, subject to the terms and
conditions set forth below.
E.
The parties also are agreeing hereby to provide for the amendment and termination of
certain agreements pursuant to which Toucan Capital and Toucan Partners are voluntarily agreeing to
relinquish certain rights, subject to the terms and conditions set forth below.
Agreement
Now, therefore
,
in consideration of the foregoing premises and the mutual covenants
and agreements hereinafter set forth, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
SECTION 1: PREFERRED STOCK CONVERSION, AND AMENDMENT OR ELIMINATION OF CERTAIN PREFERENCES,
PROTECTIONS AND SPECIAL RIGHTS
1.1 Conversion of Preferred Stock.
Effective as of the date on which the Companys securities
are admitted for trading on the Alternative Investments Market of the London Stock Exchange (the
Admission Date
), the 32,500,000 shares of Series A Preferred Stock represented by Certificate No.
CPA-1 shall be converted on a fifteen-for-one (15:1) basis into 2,166,667 shares of Common Stock of
the Company, as provided in Section 5(B) of the Certificate of Designations of Series A Preferred
Stock. Effective as of the Admission Date, the 4,816,863 shares of Series A-1 Preferred Stock
represented by Certificate No. CPA1-1 shall be converted on a fifteen-for-forty (15:40) basis into
12,844,968 shares of Common Stock of the Company, as provided in Section 5(B) of the Certificate of
Designations of Series A-1 Preferred Stock. Accordingly, in the aggregate, effective as of the
Admission Date, the shares of Preferred Stock held by Toucan Capital will be converted into an
aggregate of 15,011,635 shares of Common Stock of the Company. The parties agree that the numbers
of shares of Common Stock, per share prices and conversion ratios set forth in this Agreement give
effect to the 1-for-15 reverse stock split of Common Stock to be effected between the date hereof
and Admission.
1.2 Treatment of Accrued Dividends
. Pursuant to Section 5(D) of the Certificates of Designation,
Toucan Capital is entitled to receive, in cash or additional shares of stock, accrued and unpaid
dividends on the Preferred Stock being converted into Common Stock on the Admission Date. Such
dividends have accrued and will accrue from the date of issuance through the date of conversion
into Common Stock. In consideration of Toucan Capitals election to defer receipt of the
satisfaction of such accrued and unpaid dividends on the Admission Date
(which are currently
estimated to be approximately $1,251,791), as provided in the Certificates of Designation, the
parties hereby agree as follows:
(a) On or prior to September 30, 2007, the Company may elect to pay some or all of the
accrued and unpaid dividends in cash.
(b) To the extent that all accrued and unpaid dividend are not paid in cash on or prior to
September 30, 2007, then on or after October 1, 2007, Toucan Capital may elect, in its sole
discretion, to have the accrued and unpaid dividends satisfied, in whole or in part
(including through a combination of the following), by either: (i) cash payment; (ii) a
reduction in the exercise prices of any or all Toucan Capital Warrants, chosen in Toucan
Capitals sole discretion, such that the aggregate exercise price of such Toucan Capital
Warrants is reduced by an amount equal to the amount of accrued and unpaid dividends being
satisfied through such adjustment; or (iii) the issuance of shares of Common Stock on the
basis of $0.60 per share (after giving effect to the 1-for-15 reverse stock split of Common
Stock to be effected between the date hereof and Admission, and as further adjusted for
stock splits, stock dividends, reverse stock splits and similar actions effected after the
date of Admission).
1.3 Elimination of Liquidation Preferences
. In connection with Toucan Capitals voluntary
conversion of the Preferred Stock (excluding any accrued and unpaid dividends) into Common Stock as
provided herein and Toucan Capitals voluntary elimination of a number of rights, preferences and
protections associated with the Series A Preferred Stock and the Series A-1 Preferred Stock as
provided herein, the liquidation preference entitling Toucan Capital to certain substantial cash
payments shall terminate. In connection with Toucan Partners voluntary elimination of its
existing rights to receive Series A-1 Preferred Stock under certain notes and warrants, and
elimination of a number of rights, preferences and protections associated with the Series A-1
Preferred Stock, the liquidation preference entitling Toucan Partners to certain substantial cash
payments shall terminate.
1.4 Delivery of Stock Certificates.
Effective upon Admission, Toucan Capital agrees to deliver
its original Preferred Stock certificates to the Company for cancellation, and the Company agrees
to issue Common Stock certificates representing the shares described herein, duly registered on the
books and records of the Companys transfer agent, to Toucan Capital and Toucan Partners, as
appropriate.
1.5 Termination of Amended and Restated Binding Term Sheet, As Amended.
The parties hereby agree
that, effective upon Admission, that certain Amended and Restated Binding Term Sheet dated as of
October 22, 2004, by and between the Company and Toucan Capital, as amended through the date of
this Agreement, shall terminate and be null and void and of no further effect.
1.6 Termination of Amended and Restated Recapitalization Agreement, As Amended.
The parties agree
that, effective upon Admission, they will enter into the Termination Agreement in the form attached
hereto as
Exhibit A
.
1.7 Amendment and Restatement of Investor Rights Agreement.
The parties agree that, effective
upon Admission, they will enter into the Second Amended and Restated Investor Rights Agreement in
the form attached hereto as
Exhibit B
.
1.8 Agreements with Respect to Promissory Notes of Toucan Partners.
Toucan Partners hereby agrees
that it will not convert any portion of its convertible promissory notes into securities of the
Company before July 1, 2007. Toucan Partners further agrees that, after the Admission Date, it
will not convert any portion of its convertible promissory notes into securities other than Common
Stock. The Company hereby agrees that it will not repay any amount outstanding on any convertible
promissory notes held by Toucan Partners before June 30, 2007.
1.9 Agreements with Respect to Warrant Exercises by Toucan Partners.
Toucan Partners hereby
agrees that (i) prior to the Admission Date, it will not exercise any of the warrants that it holds
as of the date hereof (the
Toucan Partners Warrants
) to acquire any securities of the Company,
and (ii) on or after the Admission Date, it will not exercise any of the Toucan Partners Warrants
to acquire securities other than Common Stock.
1.10 Agreements with Respect to Warrant Exercises by Toucan Capital.
Toucan Capital hereby agrees
that (i) prior to the Admission Date, it will not exercise any of the warrants that it holds as of
the date hereof (the
Toucan Capital Warrants
) to acquire any securities of the Company, and (ii)
on or after the Admission Date, it will not exercise any of the Toucan Capital Warrants to acquire
securities other than Common Stock.
SECTION 2: ISSUANCE OF COMMON STOCK TO TOUCAN CAPITAL AND TOUCAN PARTNERS
In consideration for the actions to be taken as provided in Section 1, effective upon Admission
(and in addition to the shares of Common Stock to be issued pursuant to Section 1.1 hereof), the
Company shall issue 4,287,851 additional shares of Common Stock to Toucan Capital, and 2,572,710
shares of Common Stock to Toucan Partners.
SECTION 3: CONTINGENT NATURE OF THIS AGREEMENT
All of the obligations of the parties hereto are conditioned on and subject to the placing of at
least £10 million of the Companys Common Stock (the Placing) and admission of the Companys
securities for trading on the Alternative Investments Market of the London Stock Exchange
(
Admission
) on or before June 22, 2007. If the Placing and Admission do not occur on or before
June 22, 2007, this Agreement will be null and void in its entirety.
SECTION 4: MISCELLANEOUS
4.1 Share Numbers.
The parties agree that the numbers of shares of Common Stock, per share prices
and conversion ratios set forth in this Agreement give effect to the 1-for-15 reverse stock split
of Common Stock to be effected between the date hereof and Admission.
4.2 Governing Law.
This Agreement shall be governed by the internal substantive laws of the State
of Delaware, without giving effect to principles of conflict of laws thereunder, as if entered into
by two residents of Delaware and to be performed entirely within Delaware.
4.3 Successors and Assigns.
This Agreement shall be binding upon each of the parties hereto and
their respective successors and assigns (if any).
4.4 Severability.
In the event that any provision of this Agreement, or the application of any
such provision to any person or set of circumstances, shall be determined to be invalid, unlawful,
void or unenforceable to any extent, the remainder of this Agreement, and the application of such
provision to persons or circumstances other than those as to which it is determined to be invalid,
unlawful, void or unenforceable, shall not be impaired or otherwise affected and shall continue to
be valid and enforceable to the fullest extent permitted by law.
4.5 Amendments.
This Agreement may not be amended, modified, altered or supplemented other than by
means of a written instrument duly executed and delivered on behalf of each of the parties hereto.
4.6 Notices.
All notices and other communications which are required to be or may be given under
this Agreement shall be effective upon delivery, if (i) delivered in person or by courier or by
facsimile, (ii) mailed, certified first class mail, postage prepaid, return receipt requested, or
(iii) if sent by e-mail to the parties hereto at the addresses, facsimile numbers and/or e-mail
addresses set forth on the signature pages hereto or to such other address as any party shall have
furnished to the other by notice given in accordance with this Section 4.6. Each party hereby
consents to delivery of any and all corporate, stockholder and other notices from the Company by
e-mail to the address below (or any subsequent address that such party notifies the Company of in
accordance with this Section 4.6).
4.7 Counterparts.
This Agreement may be signed in one or more counterparts, including facsimile
counterparts, each of which shall constitute an original and all of which, when taken together,
shall constitute one agreement.
4.8 Toucan Partners Consent.
To the extent required pursuant to the terms of the series of
promissory notes, as amended, issued by the Company to Toucan Partners from November 14, 2005
through the date hereof, Toucan Partners hereby consents to the transactions contemplated herein.
[Signature Page Follows]
In Witness Whereof
, the parties have caused this
Conversion Agreement
to
be executed and delivered as of the date first above written.
|
|
|
|
|
|
|
|
|
|
|
Northwest Biotherapeutics, Inc.
|
|
|
|
Toucan Capital Fund II, L.P.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alton Boynton
|
|
|
|
|
|
Linda F. Powers
|
|
|
|
|
President
|
|
|
|
|
|
Managing Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address:
|
|
|
|
|
|
Address
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Northwest Biotherapeutics, Inc.
|
|
|
|
|
|
Linda F. Powers
|
|
|
|
|
Attention: Alton Boynton
|
|
|
|
|
|
Managing Director
|
|
|
|
|
18701 120th Avenue, NE,
|
|
|
|
|
|
Toucan Capital Corp.
|
|
|
|
|
Suite 101
|
|
|
|
|
|
7600 Wisconsin Ave, 7
th
Floor
|
|
|
|
|
Bothell, Washington 98011
|
|
|
|
|
|
Bethesda, MD 20814
|
|
|
|
|
Facsimile: 425.608.3009
|
|
|
|
|
|
Facsimile: 240.497.4065
|
|
|
|
|
|
|
|
|
|
|
E-Mail:lpowers@toucancapital.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Toucan Partners, LLC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Linda F. Powers
|
|
|
|
|
|
|
|
|
|
|
Managing Member
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Toucan Partners, LLC
|
|
|
|
|
|
|
|
|
|
|
7600 Wisconsin Avenue
|
|
|
|
|
|
|
|
|
|
|
Suite 700
|
|
|
|
|
|
|
|
|
|
|
Bethesda, MD 20814
|
|
|
|
|
|
|
|
|
|
|
Facsimile: 240.497.4065
|
|
|
|
|
|
|
|
|
|
|
E-Mail:lpowers@toucancapital.com
|
|
|
Counterpart Signature Page To Conversion Agreement
Exhibit A
TERMINATION AGREEMENT
Filed
separately as Exhibit 10.2 of this filing.
Exhibit B
Form of Amended and Restated Investor Rights Agreement
Filed
separately as Exhibit 10.3 of this filing.
EXHIBIT 10.3
NORTHWEST BIOTHERAPEUTICS, INC.
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
This Second Amended and Restated Investor Rights Agreement
(the
Agreement
) is
entered into as of the 22
nd
day of June, 2007, by and between
Northwest
Biotherapeutics, Inc
.
, a Delaware corporation (the
Company
),
Toucan Capital Fund II,
L.P.
(
Toucan Capital
) and Toucan Partners, LLC (
Toucan Partners
and, collectively with
Toucan Capital, the
Investors
).
Recitals
Whereas,
Toucan Capital holds shares of the Companys Series A Cumulative Convertible
Preferred Stock (the
Series A Stock
) and Series A-1 Cumulative Convertible Preferred Stock (the
Series A-1 Preferred Stock
and, together with the Series A Stock, the
Preferred Stock
) and
Toucan Capital is electing to convert all shares of Preferred Stock that it holds into shares of
Common Stock of the Company, pursuant to that certain Conversion Agreement dated of even date
herewith;
Whereas
,
Toucan Partners will receive shares of Common Stock of the Company in
conjunction with the Conversion Agreement and holds notes convertible into, and warrants
exercisable for, additional shares of capital stock of the Company;
Whereas
,
Toucan Capital and the Company are party to that certain Investor Rights
Agreement (the
Original Agreement
), which was amended and restated in its entirety by the Amended
and Restated Investor Rights Agreement (the
Amended and Restated Agreement
) on April 17, 2006;
Whereas
,
the Conversion Agreement is conditioned upon the execution and delivery of
this Agreement; and
Whereas
,
in connection with the consummation of the Conversion Agreement, the parties
desire to enter into this Agreement in order to further amend and restate the Amended and Restated
Agreement, add Toucan Partners as a party to the agreement, and to provide Investors with the
registration and other rights as set forth below, subject to the admission of the Companys Common
Stock for trading on AIM.
Now, Therefore,
in consideration of these premises and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:
SECTION 1. GENERAL.
1.1 Definitions.
As used in this Agreement the following terms shall have the following
respective meanings:
(a)
Exchange Act
means the Securities Exchange Act of 1934, as amended.
(b)
Form S-3
means such form under the Securities Act as in effect on the date hereof or any
successor or similar registration form under the Securities Act subsequently adopted by the SEC
which permits inclusion or incorporation of substantial information by reference to other documents
filed by the Company with the SEC.
(c)
Holder
means any person owning of record Registrable Securities that have not been sold
to the public or any assignee of record of such Registrable Securities in accordance with Section
2.10 hereof.
(d)
Notes
shall mean those certain convertible promissory notes held by Toucan Partners that
are convertible for shares of the Companys capital stock.
(e)
Register, registered,
and
registration
refer to a registration effected by preparing
and filing a registration statement in compliance with the Securities Act, and the declaration or
ordering of effectiveness of such registration statement or document.
(f)
Registrable Securities
means (a) Common Stock of the Company held by the Holders or
issuable or issued upon conversion of the Notes and/or Warrants and (b) any Common Stock of the
Company issued as (or issuable upon the conversion or exercise of any warrant, right or other
security which is issued as) a dividend or other distribution with respect to, or in exchange for
or in replacement of, such above-described securities. Notwithstanding the foregoing, Registrable
Securities shall not include any securities (i) sold by a person to the public either pursuant to a
registration statement or Rule 144, (ii) sold in a private transaction in which the transferors
rights under Section 2 of this Agreement are not assigned or (iii) held by a Holder (together with
its affiliates) if, as reflected on the Companys list of stockholders, such Holder (together with
its affiliates) holds less than 1% of the Companys outstanding Common Stock (treating all shares
of Preferred Stock on an as converted basis) and all shares of Common Stock of the Company issuable
or issued upon conversion of the Shares held by and issuable to such Holder (and its affiliates)
may be sold pursuant to Rule 144 during any ninety (90) day period.
(g)
Registrable Securities then outstanding
shall be the number of shares of the Companys
Common Stock that are Registrable Securities and either (a) are then issued and outstanding or (b)
are issuable pursuant to then exercisable or convertible securities.
(h)
Registration Expenses
shall mean all expenses incurred by the Company in complying with
Sections 2.2, 2.4 and 2.6 hereof, including, without limitation, all registration and filing fees,
printing expenses, fees and disbursements of counsel for the Company, reasonable fees and
disbursements not to exceed one hundred thousand dollars ($100,000) of a single special counsel for
the Holders, blue sky fees and expenses and the expense of any special audits incident to or
required by any such registration (but excluding the compensation of regular employees of the
Company which shall be paid in any event by the Company).
(i)
SEC
or
Commission
means the Securities and Exchange Commission.
(j)
Securities Act
shall mean the Securities Act of 1933, as amended.
(k)
Selling Expenses
shall mean all underwriting discounts and selling commissions
applicable to the sale.
(l)
Shares
shall mean the Companys Common Stock issued pursuant to the Conversion Agreement
held from time to time by the Investors and their permitted assigns and the Capital Stock issuable
upon conversion of the Notes or exercise of the Warrants, and any additional shares of Common Stock
acquired by the Investors after the date hereof (including additional shares of Common Stock of the
Company directly or indirectly issuable upon conversion, exchange or exercise of any securities).
(m)
Special Registration Statement
shall mean (i) a registration statement relating to any
employee benefit plan or (ii) with respect to any corporate reorganization or transaction under
Rule 145 of the Securities Act, any registration statements related to the issuance or resale of
securities issued in such a transaction or (iii) a registration related to stock issued upon
conversion of debt securities.
(n)
Warrants
shall mean those certain warrants to purchase capital stock of the Company held
by Toucan Capital dated June 1, 2007 and those certain warrants to purchase capital stock of the
Company held by Toucan Partners dated June 1, 2007, and any such additional warrants issued to
Toucan Partners thereafter.
SECTION 2.
REGISTRATION; RESTRICTIONS ON TRANSFER
.
2.1 Restrictions on Transfer.
(a)
Each Holder agrees not to make any disposition of all or any portion of the Shares or
Registrable Securities unless and until:
(i)
there is then in effect a registration statement under the Securities Act covering such
proposed disposition and such disposition is made in accordance with such registration statement;
or
(ii)
(A) The transferee has agreed in writing to be bound by the terms of this Agreement, (B)
such Holder shall have notified the Company of the proposed disposition and shall have furnished
the Company with a detailed statement of the circumstances surrounding the proposed disposition,
and (C) if reasonably requested by the Company, such Holder shall have furnished the Company with
an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not
require registration of such shares under the Securities Act. The Company will not require any
transferee pursuant to Rule 144 to be bound by the terms of this Agreement if the shares so
transferred do not remain Registrable Securities hereunder following such transfer.
(b)
Notwithstanding the provisions of subsection (a) above, no such restriction shall apply to
a transfer by a Holder that is (A) a partnership transferring to its partners or former partners in
accordance with partnership interests, (B) a corporation transferring to an affiliate, (C) a
limited liability company transferring to its members or former members in accordance with their
interest in the limited liability company, (D) an individual transferring to the Holders family
member or trust for the benefit of an individual Holder, or (E) any other party permitted
under applicable federal and state securities laws;
provided
that in each case the transferee
will agree in writing to be subject to the terms of this Agreement to the same extent as if he were
an original Holder hereunder.
(c)
Each certificate representing Shares or Registrable Securities shall be stamped or
otherwise imprinted with legends substantially similar to the following (in addition to any legend
required under applicable state securities laws):
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 (THE
ACT
) AND MAY NOT BE OFFERED, SOLD OR
OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND
UNTIL REGISTERED UNDER THE ACT OR UNLESS THE COMPANY HAS RECEIVED AN
OPINION OF COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT
SUCH REGISTRATION IS NOT REQUIRED.
THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND
CONDITIONS OF A CERTAIN INVESTOR RIGHTS AGREEMENT BY AND BETWEEN THE
STOCKHOLDER AND THE COMPANY. COPIES OF SUCH AGREEMENT MAY BE
OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.
(d)
The Company shall be obligated to reissue promptly unlegended certificates at the request
of any Holder thereof if the Holder shall have obtained an opinion of counsel (which counsel may be
counsel to the Company) reasonably acceptable to the Company to the effect that the securities
proposed to be disposed of may lawfully be so disposed of without registration, qualification and
legend,
provided that
the second legend listed above shall be removed only at such time as the
Holder of such certificate is no longer subject to any restrictions hereunder.
(e)
Any legend endorsed on an instrument pursuant to applicable state securities laws and the
stop-transfer instructions with respect to such securities shall be removed upon receipt by the
Company of an order of the appropriate blue sky authority authorizing such removal.
2.2 Demand Registration.
(a)
If holders of at least 20% of the Registrable Securities issued or issuable to the Holders
(the
Initiating Holders
) request that the Company file a registration statement on Form SB-2 or
Form S-1 (the
Registration Statement
) covering at least 10% of the Registrable Securities issued
or issuable to the Holders (or any lesser percentage if the anticipated aggregate
offering price would exceed $2,000,000), the Company shall cause the Registrable Securities to
be registered.
(b)
If the Investor intends to distribute the Registrable Securities covered by their request
by means of an underwriting, it shall so advise the Company as a part of its request made pursuant
to this Section 2.2 or any request pursuant to Section 2.4 and the Company shall include such
information in the written notice referred to in Section 2.2(a) or Section 2.4(a), as applicable.
In such event, the right of any Holder to include its Registrable Securities in such registration
shall be conditioned upon such Holders participation in such underwriting and the inclusion of
such Holders Registrable Securities in the underwriting to the extent provided herein. All
Holders proposing to distribute their securities through such underwriting shall enter into an
underwriting agreement in customary form with the underwriter or underwriters selected for such
underwriting by the Holders of a majority of the Registrable Securities held by all Initiating
Holders (which underwriter or underwriters shall be reasonably acceptable to the Company).
Notwithstanding any other provision of this Section 2.2 or Section 2.4, if the underwriter advises
the Company that marketing factors require a limitation of the number of securities to be
underwritten (including Registrable Securities) then the Company shall so advise all Holders of
Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of
shares that may be included in the underwriting shall be allocated to the Holders of such
Registrable Securities on a
pro rata
basis based on the number of Registrable Securities held by
all such Holders (including the Initiating Holders);
provided, however
, that the number of shares
of Registrable Securities to be included in such underwriting and registration shall not be reduced
unless all other securities of the Company are first entirely excluded from the underwriting and
registration. Any Registrable Securities excluded or withdrawn from such underwriting shall be
withdrawn from the registration.
(c)
The Company shall not be required to effect a registration pursuant to this Section 2.2:
(i)
if the Company has effected two (2) registrations pursuant to this Section 2.2 in the
preceding twelve (12) months, and such registrations have been declared or ordered effective; or
(ii)
if the Initiating Holders propose to dispose of shares of Registrable Securities that may
be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.4 below and
the Company undertakes promptly to file such Form S-3.
2.3 Piggyback Registrations.
The Company shall notify all Holders of Registrable Securities
in writing at least fifteen (15) days prior to the filing of any registration statement under the
Securities Act for purposes of a public offering of securities of the Company (including, but not
limited to, registration statements relating to secondary offerings of securities of the Company,
but excluding Special Registration Statements) and will afford each such Holder an opportunity to
include in such registration statement all or part of such Registrable Securities held by such
Holder. Each Holder desiring to include in any such registration statement all or any part of the
Registrable Securities held by it shall, within fifteen (15) days after the above-described notice
from the Company, so notify the Company in writing. Such notice shall state the intended method of
disposition of the Registrable Securities by such Holder.
If a Holder decides not to include all of its Registrable Securities in any registration
statement thereafter filed by the Company, such Holder shall nevertheless continue to have the
right to include any Registrable Securities in any subsequent registration statement or
registration statements as may be filed by the Company with respect to offerings of its securities,
all upon the terms and conditions set forth herein.
(a) Underwriting.
If the registration statement of which the Company gives notice under this
Section 2.3 is for an underwritten offering, the Company shall so advise the Holders of Registrable
Securities. In such event, the right of any such Holder to include Registrable Securities in a
registration pursuant to this Section 2.3 shall be conditioned upon such Holders participation in
such underwriting and the inclusion of such Holders Registrable Securities in the underwriting to
the extent provided herein. All Holders proposing to distribute their Registrable Securities
through such underwriting shall enter into an underwriting agreement in customary form with the
underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any
other provision of this Agreement, if the underwriter reasonably determines, in good faith, that
marketing factors require a limitation of the number of shares to be underwritten, the number of
shares that may be included in the underwriting shall be allocated, first, to the Company; second,
to the Holders on a
pro rata
basis based on the total number of Registrable Securities held by the
Holders; and third, to any stockholder of the Company (other than a Holder) on a
pro rata
basis;
provided, however, that no such reduction shall reduce the amount of securities of the selling
Holders included in the registration below thirty percent (30%) of the total amount of securities
included in such registration in accordance with the immediately preceding clause. In no event
will shares of any other selling stockholder be included in such registration that would reduce the
number of shares which may be included by Holders without the written consent of Holders of not
less than a majority of the Registrable Securities proposed to be sold in the offering. If any
Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw
therefrom by written notice to the Company and the underwriter, delivered at least ten (10) days
prior to the effective date of the registration statement. Any Registrable Securities excluded or
withdrawn from such underwriting shall be excluded and withdrawn from the registration. For any
Holder which is a partnership, limited liability company or corporation, the partners, retired
partners, members, retired members and stockholders of such Holder, or the estates and family
members of any such partners, retired partners, members and retired members and any trusts for the
benefit of any of the foregoing person shall be deemed to be a single Holder, and any
pro rata
reduction with respect to such Holder shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such Holder, as defined in
this sentence.
2.4
Form S-3
Registration.
In case the Company shall receive from any Holder or Holders of
Registrable Securities a written request or requests that the Company effect a registration on Form
S-3 (or any successor to Form S-3) or any similar short-form registration statement and any related
qualification or compliance with respect to all or a part of the Registrable Securities owned by
such Holder or Holders, the Company will:
(a)
promptly give written notice of the proposed registration, and any related qualification
or compliance, to all other Holders of Registrable Securities; and
(b)
as soon as practicable, effect such registration and all such qualifications and
compliances as may be so requested and as would permit or facilitate the sale and distribution of
all or such portion of such Holders or Holders Registrable Securities as are specified in such
request, together with all or such portion of the Registrable Securities of any other Holder or
Holders joining in such request as are specified in a written request given within fifteen (15)
days after receipt of such written notice from the Company;
provided, however
, that the Company
shall not be obligated to effect any such registration, qualification or compliance pursuant to
this Section 2.4:
(i)
if Form S-3 is not available for such offering by the Holders, or
(ii)
if the Holders, together with the holders of any other securities of the Company entitled
to inclusion in such registration, propose to sell Registrable Securities and such other securities
(if any) at an aggregate price to the public of less than one million dollars ($1,000,000).
(c)
Subject to the foregoing, the Company shall file a Form S-3 registration statement
covering the Registrable Securities and other securities so requested to be registered as soon as
practicable after receipt of the requests of the Holders. Registrations effected pursuant to this
Section 2.4 shall not be counted as demands for registration or registrations effected pursuant to
Section 2.2.
2.5 Expenses of Registration.
Except as specifically provided herein, all Registration
Expenses incurred in connection with any registration, qualification or compliance pursuant to
Section 2.2, 2.3 or 2.4 herein shall be borne by the Company. All Selling Expenses incurred in
connection with any registrations hereunder, shall be borne by the holders of the securities so
registered
pro rata
on the basis of the number of shares so registered. The Company shall not,
however, be required to pay for expenses of any registration proceeding begun pursuant to Section
2.2 or 2.3, the request of which has been subsequently withdrawn by the Initiating Holders unless
(a) the withdrawal is based upon material adverse information concerning the Company of which the
Initiating Holders were not aware at the time of such request or (b) the Holders of a majority of
Registrable Securities agree to deem such registration to have been effected as of the date of such
withdrawal for purposes of determining whether the Company shall be obligated pursuant to Section
2.2(c) to undertake any subsequent registration, in which event such right shall be forfeited by
all Holders). If the Holders are required to pay the Registration Expenses, such expenses shall be
borne by the holders of securities (including Registrable Securities) requesting such registration
in proportion to the number of shares for which registration was requested. If the Company is
required to pay the Registration Expenses of a withdrawn offering pursuant to clause (a) above,
then such registration shall not be deemed to have been effected for purposes of determining
whether the Company shall be obligated pursuant to Section 2.2 to undertake any subsequent
registration.
2.6 Obligations of the Company.
Whenever required to effect the registration of any
Registrable Securities, the Company shall, as expeditiously as reasonably possible:
(a)
prepare and file within sixty (60) days of the receipt of a request for registration of
Registrable Securities with the SEC a registration statement with respect to such
Registrable Securities and use all reasonable efforts to cause such registration statement to
become effective within one hundred twenty (120) days of such request, and keep such registration
statement effective until the Holder or Holders have completed the distribution related thereto.
(b)
Prepare and file with the SEC such amendments and supplements to such registration
statement and the prospectus used in connection with such registration statement as may be
necessary to comply with the provisions of the Securities Act with respect to the disposition of
all securities covered by such registration statement for the period set forth in subsection (a)
above.
(c)
Furnish to the Holders such number of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such other documents as
they may reasonably request in order to facilitate the disposition of Registrable Securities owned
by them.
(d)
Use its best efforts to register and qualify the securities covered by such registration
statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably
requested by the Holders;
provided
that the Company shall not be required in connection therewith
or as a condition thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions.
(e)
In the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing underwriter(s) of
such offering. Each Holder participating in such underwriting shall also enter into and perform
its obligations under such an agreement.
(f)
Notify each Holder of Registrable Securities covered by such registration statement at any
time when a prospectus relating thereto is required to be delivered under the Securities Act of the
happening of any event as a result of which the prospectus included in such registration statement,
as then in effect, includes an untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein not misleading in
the light of the circumstances then existing. The Company will amend or supplement such prospectus
in order to cause such prospectus not to include any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not
misleading in the light of the circumstances then existing.
(g)
Use its best efforts to furnish, on the date that such Registrable Securities are
delivered to the underwriters for sale, if such securities are being sold through underwriters, (i)
an opinion, dated as of such date, of the counsel representing the Company for the purposes of such
registration, in form and substance as is customarily given to underwriters in an underwritten
public offering, addressed to the underwriters, if any, and (ii) a letter, dated as of such date,
from the independent certified public accountants of the Company, in form and substance as is
customarily given by independent certified public accountants to underwriters in an underwritten
public offering addressed to the underwriters.
2.7 Delay of Registration; Furnishing Information.
(a)
No Holder shall have any right to obtain or seek an injunction restraining or otherwise
delaying any such registration as the result of any controversy that might arise with respect to
the interpretation or implementation of this Section 2.
(b)
It shall be a condition precedent to the obligations of the Company to take any action
pursuant to Section 2.2, 2.3 or 2.4 that the selling Holders shall furnish to the Company such
information regarding themselves, the Registrable Securities held by them and the intended method
of disposition of such securities as shall be required to effect the registration of their
Registrable Securities.
(c)
The Company shall have no obligation with respect to any registration requested pursuant
to Section 2.2 or Section 2.4 if the number of shares or the anticipated aggregate offering price
of the Registrable Securities to be included in the registration does not equal or exceed the
number of shares or the anticipated aggregate offering price required to originally trigger the
Companys obligation to initiate such registration as specified in Section 2.2 or Section 2.4,
whichever is applicable.
2.8 Liquidated Damages.
In the event that the Company shall fail to cause the Registration
Statement to be timely filed, timely declared effective as provided herein, the Company shall pay
as liquidated damages the amount of 1% per month of the aggregate purchase price for the securities
to be sold pursuant to the Registration Statement (or such lesser amount that is the maximum
permitted under applicable rules and regulations of the U.S. Small Business Administration (
SBA
))
provided, however
, that in no event shall the aggregate liquidated damages exceed ten percent (10%)
of the aggregate purchase price of the Registrable Securities proposed to be included in the
Registration Statement.
2.9 Indemnification.
In the event any Registrable Securities are included in a registration
statement under Sections 2.2, 2.3 or 2.4:
(a)
To the fullest extent permitted by law, the Company will indemnify and hold harmless each
Holder, the partners, members, officers and directors of each Holder, any underwriter (as defined
in the Securities Act) for such Holder and each person, if any, who controls such Holder or
underwriter within the meaning of the Securities Act or the Exchange Act, against any losses,
claims, damages, or liabilities (joint or several) other than consequential losses of any kind, to
which they may become subject under the Securities Act, the Exchange Act or other federal or state
law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise
out of or are based upon any of the following statements, omissions or violations (collectively a
Violation
) by the Company: (i) any untrue statement or alleged untrue statement of a material
fact contained in such registration statement or incorporated reference therein, including any
preliminary prospectus or final prospectus contained therein or any amendments or supplements
thereto, (ii) the omission or alleged omission to state therein a material fact required to be
stated therein, or necessary to make the statements therein not misleading, or (iii) any violation
or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities
law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state
securities law in connection with the offering covered by
such registration statement; and the Company will reimburse each such Holder, partner, member,
officer, director, underwriter or controlling person for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss, claim, damage,
liability or action;
provided however
, that the indemnity agreement contained in this Section
2.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or
action if such settlement is effected without the consent of the Company, which consent shall not
be unreasonably withheld, nor shall the Company be liable in any such case for any such loss,
claim, damage, liability or action to the extent that it arises out of or is based upon a Violation
which occurs in reliance upon and in conformity with written information furnished expressly for
use in connection with such registration by such Holder, partner, member, officer, director,
underwriter or controlling person of such Holder.
(b)
To the extent permitted by law, each Holder will, if Registrable Securities held by such
Holder are included in the securities as to which such registration qualifications or compliance is
being effected, indemnify and hold harmless the Company, each of its directors, its officers and
each person, if any, who controls the Company within the meaning of the Securities Act, any
underwriter and any other Holder selling securities under such registration statement or any of
such other Holders partners, directors or officers or any person who controls such Holder, against
any losses, claims, damages or liabilities (joint or several) to which the Company or any such
director, officer, controlling person, underwriter or other such Holder, or partner, director,
officer or controlling person of such other Holder may become subject under the Securities Act, the
Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities
(or actions in respect thereto) arise out of or are based upon any of the following statements: (i)
any untrue statement or alleged untrue statement of a material fact contained in such registration
statement or incorporated reference therein, including any preliminary prospectus or final
prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged
omission to state therein a material fact required to be stated therein, or necessary to make the
statements therein not misleading, or (iii) any violation or alleged violation by the Company of
the Securities Act (collectively, a
Holder Violation
), in each case to the extent (and only to
the extent) that such Holder Violation occurs in reliance upon and in conformity with written
information furnished by such Holder under an instrument duly executed by such Holder and stated to
be specifically for use in connection with such registration; and each such Holder will reimburse
any legal or other expenses reasonably incurred by the Company or any such director, officer,
controlling person, underwriter or other Holder, or partner, officer, director or controlling
person of such other Holder in connection with investigating or defending any such loss, claim,
damage, liability or action if it is judicially determined that there was such a Holder Violation;
provided, however,
that the indemnity agreement contained in this Section 2.9(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement
is effected without the consent of the Holder, which consent shall not be unreasonably withheld;
provided further
, that in no event shall any indemnity under this Section 2.9 exceed the net
proceeds from the offering received by such Holder.
(c)
Promptly after receipt by an indemnified party under this Section 2.9 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 2.9,
deliver to the indemnifying party a written notice of the commencement
thereof and the indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to
assume the defense thereof with counsel mutually satisfactory to the parties;
provided, however,
that an indemnified party shall have the right to retain its own counsel, with the fees and
expenses thereof to be paid by the indemnifying party, if representation of such indemnified party
by the counsel retained by the indemnifying party would be inappropriate due to actual or potential
differing interests between such indemnified party and any other party represented by such counsel
in such proceeding. The failure to deliver written notice to the indemnifying party within a
reasonable time of the commencement of any such action shall relieve such indemnifying party of any
liability to the indemnified party under this Section 2.9 to the extent, and only to the extent,
prejudicial to its ability to defend such action, but the omission so to deliver written notice to
the indemnifying party will not relieve it of any liability that it may have to any indemnified
party otherwise than under this Section 2.9.
(d)
If the indemnification provided for in this Section 2.9 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any losses, claims, damages
or liabilities referred to herein, the indemnifying party, in lieu of indemnifying such indemnified
party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or
payable by such indemnified party as a result of such loss, claim, damage or liability in such
proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other in connection with the Violation(s) or Holder
Violation(s) that resulted in such loss, claim, damage or liability, as well as any other relevant
equitable considerations. The relative fault of the indemnifying party and of the indemnified
party shall be determined by a court of law by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party and the parties
relative intent, knowledge, access to information and opportunity to correct or prevent such
statement or omission;
provided
,
that
in no event shall any contribution by a Holder hereunder
exceed the net proceeds from the offering received by such Holder.
(e)
The obligations of the Company and Holders under this Section 2.9 shall survive completion
of any offering of Registrable Securities in a registration statement and, with respect to
liability arising from an offering to which this Section 2.9 would apply that is covered by a
registration filed before termination of this Agreement, such termination. No indemnifying party,
in the defense of any such claim or litigation, shall, except with the consent of each indemnified
party, consent to entry of any judgment or enter into any settlement which does not include as an
unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a
release from all liability in respect to such claim or litigation.
(f)
Notwithstanding any of the foregoing provisions of this Section 2.9, no party shall be
entitled to indemnification against any consequential damages.
2.10 Assignment of Registration Rights.
The rights to cause the Company to register
Registrable Securities pursuant to this Section 2 may be assigned by a Holder to a transferee or
assignee of Registrable Securities (for so long as such shares remain Registrable Securities) that
(a) is a subsidiary, parent, general partner, limited partner, retired partner, member or retired
member, or stockholder of a Holder that is a corporation, partnership or limited liability
company, (b) is a Holders family member or trust for the benefit of an individual Holder, (c)
acquires at least one million (1,000,000) shares of Registrable Securities (as adjusted for stock
splits and combinations); (d) is an entity affiliated by common control (or other related entity)
with such Holder, or (e) is any other permitted assignee or transferee under applicable federal and
state securities laws,
provided, however,
(i) the transferor shall, within ten (10) days after such
transfer, furnish to the Company written notice of the name and address of such transferee or
assignee and the securities with respect to which such registration rights are being assigned and
(ii) such transferee shall agree to be subject to all restrictions set forth in this Agreement.
2.11 Limitation on Subsequent Registration Rights.
Without the consent of the holders of a
majority of the Registrable Securities, after the date of this Agreement, the Company shall not
enter into any agreement with any holder or prospective holder of any securities of the Company
that would grant such holder rights to demand the registration of shares of the Companys capital
stock, or to include such shares in a registration statement that would reduce the number of shares
includable by the Holders.
2.12 Agreement to Furnish Information.
If requested by the Company or the representative of
the underwriters of Common Stock (or other securities) of the Company, each Holder shall provide,
within ten (10) days of such request, such information as may be required by the Company or such
representative in connection with the completion of any public offering of the Companys securities
pursuant to a registration statement filed under the Securities Act. The obligations described in
this Section 2.12 shall not apply to a Special Registration Statement. The Company may impose
stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject
to the foregoing restriction until the end of said day period. Each Holder agrees that any
transferee of any shares of Registrable Securities shall be bound by this Section 2.12. The
underwriters of the Companys stock are intended third party beneficiaries of this Section 2.12 and
shall have the right, power and authority to enforce the provisions hereof as though they were a
party hereto.
2.13 Rule 144 Reporting.
With a view to making available to the Holders the benefits of
certain rules and regulations of the SEC which may permit the sale of the Registrable Securities to
the public without registration, the Company agrees to use its best efforts to:
(a)
Make and keep public information available, as those terms are understood and defined in
SEC Rule 144 or any similar or analogous rule promulgated under the Securities Act, at all times
after the effective date of the first registration filed by the Company for an offering of its
securities to the general public;
(b)
File with the SEC, in a timely manner, all reports and other documents required of the
Company under the Exchange Act; and
(c)
So long as a Holder owns any Registrable Securities, furnish to such Holder forthwith upon
request: a written statement by the Company as to its compliance with the reporting requirements
of said Rule 144 of the Securities Act, and of the Exchange Act (at any time after it has become
subject to such reporting requirements); a copy of the most recent annual or quarterly report of
the Company filed with the Commission; and such other reports and
documents as a Holder may reasonably request in connection with availing itself of any rule or
regulation of the SEC allowing it to sell any such securities without registration.
SECTION 3.
COVENANTS OF THE COMPANY
.
3.1 Qualified Small Business.
The Company will use best efforts to comply with the reporting
and recordkeeping requirements of Section 1202 of the Internal Revenue Code of 1986, as amended
(the
Code
), any regulations promulgated thereunder and any similar state laws and regulations and
agrees not to repurchase any stock of the Company if such repurchase would cause the Shares not to
so qualify as Qualified Small Business Stock, so long as the Companys Board of Directors
determines that it is in the best interests of and not unduly burdensome to the Company to comply
with the provisions of Section 1202 of the Code.
3.2 Certain Covenants Relating to SBA Matters.
(a) Use of Proceeds.
The Company has used, and shall continue to use, the proceeds from the
sale of the Preferred Stock (the Proceeds) for its growth, modernization or expansion. The
Company shall provide each Investor which is a licensed Small Business Investment Company (an
SBIC
Investor
) and the SBA reasonable access to the Companys books and records for the purpose of
confirming the use of Proceeds.
(b) Business Activity.
For so long as any SBIC Investor holds any securities of the Company,
the Company shall not change the nature of its business activity if such change would render the
Company ineligible as provided in 13 C.F.R. Section 107.720.
(c) Compliance.
So long as any SBIC Investor holds any securities of the Company, the Company
will at all times comply with the non-discrimination requirements of 13 C.F.R. Parts 112, 113 and
117.
(d) Information for SBIC Investor.
Within forty five (45) days after the end of each fiscal
year and at such other times as an SBIC Investor may reasonably request, the Company shall deliver
to such SBIC Investor a written assessment, in form and substance reasonably satisfactory to such
SBIC Investor, of the economic impact of such SBIC Investors financing specifying the full-time
equivalent jobs created or retained in connection with such investment, and the impact of the
financing on the Companys business in terms of profits and on taxes paid by the Company and its
employees. Upon request, the Company agrees to promptly provide each SBIC Investor with sufficient
information to permit such Investor to comply with their obligations under the Small Business
Investment Act of 1958, as amended, and the regulations promulgated thereunder and related thereto;
provided, however,
each SBIC Investor agrees that it will protect any information which the Company
labels as confidential to the extent permitted by law. Any submission of any financial information
under this Section shall include a certificate of the Companys president, chief executive officer,
treasurer or chief financial officer.
(e) Number of Holders of Voting Securities.
So long as any SBIC Investor holds any securities
purchased pursuant to the Purchase Agreement or issued by the Company with respect thereto, the
Company shall notify each SBIC Investor (i) at least fifteen (15) days prior to taking any action
after which the number of record holders of the Companys voting
securities would be increased from fewer than fifty (50) to fifty (50) or more, and (ii) of
any other action or occurrence after which the number of record holders of the Companys voting
securities was increased (or would increase) from fewer than fifty (50) to fifty (50) or more, as
soon as practicable after the Company becomes aware that such other action or occurrence has
occurred or is proposed to occur.
SECTION 4.
MISCELLANEOUS
.
4.1 Effectiveness of this Agreement.
This Agreement shall be effective immediately upon
Admission.
4.2 Governing Law.
This Agreement shall be governed by and construed under the laws of the
State of Delaware in all respects as such laws are applied to agreements among Delaware residents
entered into and to be performed entirely within Delaware, without reference to conflicts of laws
or principles thereof. The parties agree that any action brought by either party under or in
relation to this Agreement, including without limitation to interpret or enforce any provision of
this Agreement, shall be brought in, and each party agrees to and does hereby submit to the
jurisdiction and venue of, any state or federal court located in the County of Wilmington,
Delaware.
4.3 Successors and Assigns.
Except as otherwise expressly provided herein, the provisions
hereof shall inure to the benefit of, and be binding upon, the parties hereto and their respective
successors, assigns, heirs, executors, and administrators and shall inure to the benefit of and be
enforceable by each person who shall be a holder of Registrable Securities from time to time;
provided, however
, that prior to the receipt by the Company of adequate written notice of the
transfer of any Registrable Securities specifying the full name and address of the transferee, the
Company may deem and treat the person listed as the holder of such shares in its records as the
absolute owner and holder of such shares for all purposes, including the payment of dividends or
any redemption price.
4.4 Entire Agreement.
This Agreement, the Exhibits and Schedules hereto, the Purchase
Agreement and the other documents delivered pursuant thereto constitute the full and entire
understanding and agreement between the parties with regard to the subjects hereof and no party
shall be liable or bound to any other in any manner by any oral or written representations,
warranties, covenants and agreements except as specifically set forth herein and therein. Each
party expressly represents and warrants that it is not relying on any oral or written
representations, warranties, covenants or agreements outside of this Agreement.
4.5 Severability.
In the event one or more of the provisions of this Agreement should, for
any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity,
illegality, or unenforceability shall not affect any other provisions of this Agreement, and this
Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been
contained herein.
4.6 Amendment and Waiver.
(a)
Except as otherwise expressly provided, this Agreement may be amended or modified, and
the obligations of the Company and the rights of the Holders under this
Agreement may be waived, only upon the written consent of the Company and the holders of at
least a majority of the then-outstanding Registrable Securities.
(b)
For the purposes of determining the number of Holders entitled to vote or exercise any
rights hereunder, the Company shall be entitled to rely solely on the list of record holders of its
stock as maintained by or on behalf of the Company.
4.7 Delays or Omissions.
It is agreed that no delay or omission to exercise any right, power,
or remedy accruing to any party, upon any breach, default or noncompliance by another party under
this Agreement shall impair any such right, power, or remedy, nor shall it be construed to be a
waiver of any such breach, default or noncompliance, or any acquiescence therein, or of any similar
breach, default or noncompliance thereafter occurring. It is further agreed that any waiver,
permit, consent, or approval of any kind or character on any partys part of any breach, default or
noncompliance under the Agreement or any waiver on such partys part of any provisions or
conditions of this Agreement must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, either under this Agreement, by law, or
otherwise afforded to any party, shall be cumulative and not alternative.
4.8 Notices.
All notices required or permitted hereunder shall be in writing and shall be
deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by
confirmed electronic mail or facsimile if sent during normal business hours of the recipient; if
not, then on the next business day, (c) five (5) days after having been sent by registered or
certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a
nationally recognized overnight courier, specifying next day delivery, with written verification of
receipt. All communications shall be sent to the party to be notified at the address as set forth
on the signature pages hereof or at such other address or electronic mail address as such party may
designate by ten (10) days advance written notice to the other parties hereto.
4.9 Titles and Subtitles.
The titles of the sections and subsections of this Agreement are
for convenience of reference only and are not to be considered in construing this Agreement.
4.10 Counterparts.
This Agreement may be executed in any number of counterparts, each of
which shall be an original, but all of which together shall constitute one instrument.
4.11 Aggregation of Stock.
All shares of Registrable Securities held or acquired by
affiliated entities or persons or persons or entities under common management or control shall be
aggregated together for the purpose of determining the availability of any rights under this
Agreement.
4.12 Pronouns.
All pronouns contained herein, and any variations thereof, shall be deemed to
refer to the masculine, feminine or neutral, singular or plural, as to the identity of the parties
hereto may require.
4.13 Termination.
This Agreement shall terminate and be of no further force or effect upon an
Acquisition.
[Signature Page Follows]
In Witness Whereof,
the parties hereto have executed this
Second
Amended
and Restated
Investor Rights Agreement
as of the date set forth in the first
paragraph hereof.
|
|
|
|
|
|
|
COMPANY:
|
|
INVESTORS:
|
|
|
|
|
|
|
|
Northwest Biotherapeutics, Inc.
|
|
Toucan Capital Fund II, L.P.
|
|
|
|
|
|
|
|
18701 120
th
Avenue, NE
|
|
7600 Wisconsin Avenue
|
Suite 101
|
|
Suite 700
|
Bothell, WA 98011
|
|
Bethesda, MD 20814
|
|
|
|
|
|
|
|
By:
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title:
|
|
|
|
Title:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Toucan Partners, LLC
|
|
|
|
|
|
|
|
|
|
|
|
7600 Wisconsin Avenue
|
|
|
|
|
Suite 700
|
|
|
|
|
Bethesda, MD 20814
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title:
|
|
|
|
|
|
|
|
|
|
EXHIBIT 10.5
Northwest Biotherapeutics, Inc.
2007 Stock Option Plan
Approved By Board: April 15, 2007
Effective Date: April 22, 2007
Approved By Stockholders:
, 2007
Termination Date: April 14, 2017
1.
General
.
(a) Eligible Option Recipients
. The persons eligible to receive Options are Employees,
Directors and Consultants.
(b) Available Options
. The Plan provides for the grant of the following: (i) Incentive Stock
Options and (ii) Nonstatutory Stock Options.
(c) General Purpose
. The Company, by means of the Plan, seeks to secure and retain the
services of the group of persons eligible to receive Options as set forth in Section 1(a), to
provide incentives for such persons to exert maximum efforts for the success of the Company and any
Affiliate and to provide a means by which such eligible recipients may be given an opportunity to
benefit from increases in value of the Common Stock through the granting of Options.
2.
Administration
.
(a) Administration by Board
. The Board shall administer the Plan unless and until the Board
delegates administration of the Plan to a Committee or Committees, as provided in Section 2(c).
(b) Powers of Board
. The Board shall have the power, subject to, and within the limitations
of, the express provisions of the Plan:
(i)
To determine from time to time (A) which of the persons eligible under the Plan shall be
granted Options; (B) when and how each Option shall be granted; (C) what type or combination of
types of Option shall be granted; (D) the provisions of each Option granted (which need not be
identical), including, without limitation, the vesting schedule and terms, and the time or times
when a person shall be permitted to receive cash or Common Stock pursuant to an Option; and (E) the
number of shares of Common Stock with respect to which an Option shall be granted to each such
person.
(ii)
To construe and interpret the Plan and Options, and to establish, amend and revoke rules
and regulations for the Plans administration. The Board, in the exercise of this power, may
correct any defect, omission or inconsistency in the Plan or in any Option Agreement in a manner
and to the extent it shall deem necessary or expedient to make the Plan or Option fully effective.
(iii)
To settle all controversies regarding the Plan and Options.
(iv)
On an extraordinary basis, to determine case by case whether to accelerate the time at
which an Option may first be exercised or the time during which an Option or any part thereof will
vest in accordance with the Plan, notwithstanding the provisions in the Option stating the time at
which it may first be exercised or the time during which it will vest, to the extent that such
acceleration will not trigger taxation under Section 409A of the Code.
(v)
To suspend or terminate the Plan at any time. Suspension or termination of the Plan shall
not impair rights and obligations under any Option granted while the Plan is in effect except with
the written consent of the affected Participant.
(vi)
To amend the Plan in any respect the Board deems necessary or advisable, including,
without limitation, relating to Incentive Stock Options and certain nonqualified deferred
compensation under Section 409A of the Code and to bring the Plan and/or Options into compliance
therewith, subject to the limitations, if any, of applicable law. However, except as provided in
Section 9(a) relating to Capitalization Adjustments, stockholder approval shall be required, but
only to the extent required by applicable law or listing requirements, for any amendment of the
Plan that either (A) materially increases the number of shares of Common Stock available for
issuance under the Plan, (B) materially expands the class of individuals eligible to receive
Options under the Plan, (C) materially increases the benefits accruing to Participants under the
Plan or materially reduces the price at which shares of Common Stock may be issued or purchased
under the Plan, (D) materially extends the term of the Plan, or (E) expands the types of stock
awards available for issuance under the Plan, Except as provided above, rights under any Option
granted before amendment of the Plan shall not be impaired by any amendment of the Plan unless (1)
the Company requests the consent of the affected Participant, and (2) such Participant consents in
writing.
(vii)
To submit any amendment to the Plan for stockholder approval, including, but not limited
to, amendments to the Plan intended to satisfy the requirements of (A) Section 162(m) of the Code
and the regulations thereunder regarding the exclusion of performance-based compensation from the
limit on corporate deductibility of compensation paid to Covered Employees, (B) Section 422 of the
Code regarding incentive stock options or (C) Rule 16b-3.
(viii)
To approve forms of Option Agreements for use under the Plan and to amend the terms of
any one or more Options, including, but not limited to, amendments to provide terms more favorable
to the Participant than previously provided in the Option Agreement, subject to any specified
limits in the Plan that are not subject to Board discretion;
provided however,
that the
Participants rights under any Option shall not be impaired by any such amendment unless (A) the
Company requests the consent of the affected Participant, and (B) such Participant consents in
writing. Notwithstanding the foregoing, subject to the limitations of applicable law, if any, and
without the affected Participants consent, the Board may amend the terms of any one or more
Options if necessary to maintain the qualified status of the Option as an Incentive Stock Option or
to bring the Option into compliance with Section 409A of the Code and Department of Treasury
regulations and other interpretive guidance issued thereunder, including without limitation any
such regulations or other guidance that may be issued or amended after the Effective Date.
2.
(ix)
Generally, to exercise such powers and to perform such acts as the Board deems necessary
or expedient to promote the best interests of the Company and that are not in conflict with the
provisions of the Plan or Options.
(x)
To adopt such procedures and sub-plans as are necessary or appropriate to permit
participation in the Plan by Employees, Directors or Consultants who are foreign nationals or
employed outside the United States.
(c) Delegation to Committee
.
(i) General
. The Board may delegate some or all of the administration of the Plan to a
Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee
shall have, in connection with the administration of the Plan, the powers theretofore possessed by
the Board that have been delegated to the Committee, including the power to delegate to a
subcommittee of the Committee any of the administrative powers the Committee is authorized to
exercise (and references in this Plan to the Board shall thereafter be to the Committee or
subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the
Plan, as may be adopted from time to time by the Board. The Board may retain the authority to
concurrently administer the Plan with the Committee and may, at any time, revest in the Board some
or all of the powers previously delegated to the Committee, Committees, subcommittee or
subcommittees.
(ii) Section 162(m) and Rule 16b-3 Compliance
. In the sole discretion of the Board, the
Committee may consist solely of two (2) or more Outside Directors, in accordance with Section
162(m) of the Code, or solely of two (2) or more Non-Employee Directors, in accordance with Rule
16b-3. In addition, the Board or the Committee, in its sole discretion, may (A) delegate to a
Committee which need not consist of Outside Directors the authority to grant Options to eligible
persons who are either (1) not then Covered Employees and are not expected to be Covered Employees
at the time of recognition of income resulting from such Option, or (2) not persons with respect to
whom the Company wishes to comply with Section 162(m) of the Code, or (B) delegate to a Committee
which need not consist of Non-Employee Directors the authority to grant Options to eligible persons
who are not then subject to Section 16 of the Exchange Act.
(d) Effect of Boards Decision
. All determinations, interpretations and constructions made by
the Board in good faith shall not be subject to review by any person and shall be final, binding
and conclusive on all persons.
3.
Shares Subject to the Plan
.
(a)
Subject to the provisions of Section 9 relating to adjustments upon changes in stock, the
aggregate number of shares of Common Stock of the Company that may be issued pursuant to Options
after the Effective Date shall not exceed Five Million Four Hundred Eighty Thousand Eight Hundred
Sixty-Eight (5,480,868) shares (the foregoing number of shares gives effect to the 1-for-15 reverse
stock split of the Common Stock effected on June 19, 2007). For clarity, the limitation in this
subsection 3(a) is a limitation in the number of shares of Common Stock that may be issued pursuant
to the Plan. Accordingly, this subsection 3(a) does not limit the granting of Options except as
provided in subsection 7(a). Shares may be issued in
3.
connection with a merger or acquisition as permitted by NASD Rule 4350(i)(1)(A)(iii) or, if
applicable, NYSE Listed Company Manual Section 303A.08, or AMEX Company Guide Section 711 and such
issuance shall not reduce the number of shares available for issuance under the Plan. Furthermore,
if an Option (i) expires or otherwise terminates without having been exercised in full or (ii) is
settled in cash (
i.e.
, the holder of the Option receives cash rather than stock), such expiration,
termination or settlement shall not reduce (or otherwise offset) the number of shares Common Stock
that may be issued pursuant to the Plan.
(b)
If any shares of common stock issued pursuant to an Option are forfeited back to the
Company because of the failure to meet a contingency or condition required to vest such shares in
the Participant, then the shares which are forfeited shall revert to and again become available for
issuance under the Plan. Also, any shares reacquired by the Company pursuant to subsection 8(g) or
as consideration for the exercise of an Option shall again become available for issuance under the
Plan. Notwithstanding the provisions of this subsection 3(b), any such shares shall not be
subsequently issued pursuant to the exercise of Incentive Stock Options.
(c) Incentive Stock Option Limit
. Notwithstanding anything to the contrary in this Section
3(c), subject to the provisions of Section 9(a) relating to Capitalization Adjustments the
aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of
Incentive Stock Options shall be Five Million Four Hundred Eighty Thousand Eight Hundred
Sixty-Eight (5,480,868) shares of Common Stock (the foregoing number of shares gives effect to the
1-for-15 reverse stock split of the Common Stock effected on June 19, 2007).
(d) Section
162(m)
Limitation on Annual Grants
. Subject to the provisions of Section 9(a)
relating to Capitalization Adjustments, at such time as the Company may be subject to the
applicable provisions of Section 162(m) of the Code, no Employee shall be eligible to be granted
during any calendar year Options whose value is determined by reference to an increase over an
exercise or strike price of at least one hundred percent (100%) of the Fair Market Value on the
date the Option is granted covering more than Five Million (5,000,000) shares of Common Stock (the
foregoing number of shares gives effect to the 1-for-15 reverse stock split of the Common Stock
effected on June 19, 2007).
(e) Source of Shares
. The stock issuable under the Plan shall be shares of authorized but
unissued or reacquired Common Stock, including shares repurchased by the Company on the market or
otherwise.
4.
Eligibility
.
(a) Eligibility for Specific Options
. Incentive Stock Options may be granted only to
employees of the Company or a parent corporation or subsidiary corporation (as such terms are
defined in Sections 424(e) and (f) of the Code). Options other than Incentive Stock Options may be
granted to Employees, Directors and Consultants.
(b) Ten Percent Stockholders
. A Ten Percent Stockholder shall not be granted an Incentive
Stock Option unless the exercise price of such Option is at least one hundred ten percent (110%) of
the Fair Market Value on the date of grant, and the Option is not exercisable after the expiration
of five (5) years from the date of grant, provided however, that Ten Percent
Stockholders may be granted Non-qualified Stock Options at any exercise price and exercise
terms agreed by the parties (subject to Section 5 hereof).
4.
(c) Consultants
. A Consultant shall be eligible for the grant of an Option only if, at the
time of grant, a Form S-8 Registration Statement under the Securities Act (
Form S-8
) is available
to register either the offer or the sale of the Companys securities to such Consultant because of
the nature of the services that the Consultant is providing to the Company, because the Consultant
is a natural person, or because of any other rule governing the use of Form S-8.
5.
Option Provisions
.
Each Option shall be in such form and shall contain such terms and conditions as the Board
shall deem appropriate. All Options shall be separately designated Incentive Stock Options or
Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate
certificate or certificates shall be issued for shares of Common Stock purchased on exercise of
each type of Option. If an Option is not specifically designated as an Incentive Stock Option,
then the Option shall be a Nonstatutory Stock Option. The provisions of separate Options need not
be identical;
provided, however
, that each Option Agreement shall include (through incorporation of
provisions hereof by reference in the Option Agreement or otherwise) the substance of each of the
following provisions:
(a) Term
. Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the
term (which need not be the same for different option grants) shall be determined by the Board and
set forth in the Option Grant Agreement. No Option shall be exercisable after the expiration of
ten (10) years from the date of its grant or such shorter period specified in the Option Agreement.
(b) Exercise Price
. Subject to the provisions of Section 4(b) regarding Ten Percent
Stockholders, the exercise price of each Option shall be not less than one hundred percent (100%)
of the Fair Market Value of the Common Stock subject to the Option on the date the Option is
granted. Notwithstanding the foregoing, an Option may be granted with an exercise price at any
level below one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the
Option if such Option is granted pursuant to an assumption of or substitution for another option in
a manner consistent with the provisions of Section 424(a) of the Code (whether or not such options
are Incentive Stock Options), or in the event the Board determines such grant to be in the best
interests of the Company to attract or retain a specific Employee, Director or Consultant.
(c) Consideration
. The purchase price of Common Stock acquired pursuant to the exercise of an
Option shall be paid, to the extent permitted by applicable law and as determined by the Board in
its sole discretion, by any combination of the methods of payment set forth below. The Board shall
have the authority to grant Options that do not permit all of the following methods of payment (or
otherwise restrict the ability to use certain methods) and to grant Options that require the
consent of the Company to utilize a particular method of payment. The methods of payment permitted
by this Section 5(c) are:
(i)
by cash, check, bank draft or money order payable to the Company;
5.
(ii)
pursuant to a program developed under Regulation T as promulgated by the Federal Reserve
Board that, prior to the issuance of the stock subject to the Option, results in either the receipt
of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate
exercise price to the Company from the sales proceeds; or
(iii)
in any other form of legal consideration that may be acceptable to the Board.
(d) Transferability of Options
. The Board may, in its sole discretion, impose such
limitations on the transferability of Options (or Shares issued pursuant to an exercise of an
Option) as the Board shall determine. In the absence of such a determination by the Board to the
contrary, the following restrictions on the transferability of Options shall apply:
(i) Restrictions on Transfer
. An Option shall not be transferable except by will or by the
laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder
only by the Optionholder;
provided, however
, that the Board may, in its sole discretion, permit
transfer of the Option in a manner consistent with applicable tax and securities laws upon the
Optionholders request.
(ii) Domestic Relations Orders
. Notwithstanding the foregoing, an Option may be transferred
pursuant to a domestic relations order,
provided, however
, that an Incentive Stock Option may be
deemed to be a Nonqualified Stock Option as a result of such transfer.
(iii) Beneficiary Designation
. Notwithstanding the foregoing, the Optionholder may, by
delivering written notice to the Company, in a form provided by or otherwise satisfactory to the
Company, designate a third party who, in the event of the death of the Optionholder, shall
thereafter be the beneficiary of an Option with the right to exercise the Option and receive the
Common Stock or other consideration resulting from an Option exercise.
(e) Vesting Generally
. The total number of shares of Common Stock subject to an Option may
vest and therefore become exercisable in periodic installments that may or may not be equal. The
Option may be subject to such other terms and conditions on the time or times when it may or may
not be exercised as the Board may deem appropriate. The vesting provisions of individual Options
may vary. The provisions of this Section 5(e) are subject to any Option provisions governing the
minimum number of shares of Common Stock as to which an Option may be exercised.
(f) Termination of Continuous Service
. Except as otherwise provided in the applicable Option
Agreement or other agreement between the Optionholder and the Company, or as otherwise required to
comply with Section 409A of the Code, in the event that an Optionholders Continuous Service
terminates (other than for Cause or upon the Optionholders death or Disability), the Optionholder
may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such
Option as of the date of termination of Continuous Service) but only within such period of time as
the Board may specify or, in the absence of specification by the Board, ending on the earlier of
(i) the date thirty (30) days following the termination of the Optionholders Continuous Service
(or such longer or shorter period specified in the Option Agreement), or (ii) the expiration of the
term of the Option as set forth in the Option Agreement. If, after termination of Continuous
Service, the Optionholder does not
exercise his or her Option within the time specified herein or in the Option Agreement (as
applicable), the Option shall terminate.
6.
(g) Extension of Termination Date
. An Optionholders Option Agreement may provide that if the
exercise of the Option following the termination of the Optionholders Continuous Service (other
than for Cause or upon the Optionholders death or Disability) would be prohibited at any time
solely because the issuance of shares of Common Stock would violate the registration requirements
under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration of a
period of thirty (30) days after the termination of the Optionholders Continuous Service during
which the exercise of the Option would not be in violation of such registration requirements, or
(ii) the expiration of the term of the Option as set forth in the Option Agreement; provided,
however, that such thirty (30) day period described in (i) may be modified to the extent required
to comply with Section 409A of the Code.
(h) Disability of Optionholder
. In the event that an Optionholders Continuous Service
terminates as a result of the Optionholders Disability, the Optionholder may exercise his or her
Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of
termination of Continuous Service), but only within such period of time ending on the earlier of
(i) the date six (6) months following such termination of Continuous Service (or such longer or
shorter period specified in the Option Agreement), or (ii) the expiration of the term of the Option
as set forth in the Option Agreement. If, after termination of Continuous Service, the
Optionholder does not exercise his or her Option within the time specified herein or in the Option
Agreement (as applicable), the Option shall terminate.
(i) Death of Optionholder
. In the event that (i) an Optionholders Continuous Service
terminates as a result of the Optionholders death, or (ii) the Optionholder dies within the period
(if any) specified in the Option Agreement after the termination of the Optionholders Continuous
Service for a reason other than death, then the Option may be exercised (to the extent the
Optionholder was entitled to exercise such Option as of the date of death) by the Optionholders
estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a
person designated as the beneficiary of the Option upon the Optionholders death, but only within
the period ending on the earlier of (A) the date twelve (12) months following the date of death (or
such longer or shorter period specified in the Option Agreement), or (B) the expiration of the term
of such Option as set forth in the Option Agreement. If, after the Optionholders death, the
Option is not exercised within the time specified herein or in the Option Agreement (as
applicable), the Option shall terminate. If the Optionholder designates a third party beneficiary
of the Option in accordance with Section 5(d)(iii), then upon the death of the Optionholder such
designated beneficiary shall have the sole right to exercise the Option and receive the Common
Stock or other consideration resulting from an Option exercise.
(j) Termination for Cause
. Except as explicitly provided otherwise in an Optionholders
Option Agreement, in the event that an Optionholders Continuous Service is terminated for Cause,
the Option shall terminate upon the termination date of such Optionholders Continuous Service, and
the Optionholder shall be prohibited from exercising his or her Option from and after the time of
such termination of Continuous Service.
7.
(k) Non-Exempt Employees
. No Option granted to an Employee that is a non-exempt employee for
purposes of the Fair Labor Standards Act shall be first exercisable for any shares of Common Stock
until at least six (6) months following the date of grant of the Option. The foregoing provision
is intended to operate so that any income derived by a non-exempt employee in connection with the
exercise or vesting of an Option will be exempt from his or her regular rate of pay.
6.
Reserved
.
7.
Covenants of the Company
.
(a) Availability of Shares
. During the terms of the Options, the Company shall keep available
at all times the number of shares of Common Stock reasonably required to satisfy such Options.
(b) Securities Law Compliance
. The Company shall seek to obtain from each regulatory
commission or agency having jurisdiction over the Plan such authority as may be required to grant
Options and to issue and sell shares of Common Stock upon exercise of the Options;
provided,
however
, that this undertaking shall not require the Company to register under the Securities Act
the Plan, any Option or any Common Stock issued or issuable pursuant to any such Option. If, after
reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency
the authority that counsel for the Company deems necessary for the lawful issuance and sale of
Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue
and sell Common Stock upon exercise of such Options unless and until such authority is obtained.
(c) No Obligation to Notify
. The Company shall have no duty or obligation to any holder of an
Option to advise such holder as to the time or manner of exercising such Option. Furthermore, the
Company shall have no duty or obligation to warn or otherwise advise such holder of a pending
termination or expiration of an Option or a possible period in which the Option may not be
exercised. The Company has no duty or obligation to minimize the tax consequences of an Option to
the holder of such Option.
8.
Miscellaneous
.
(a) Use of Proceeds from Sales of Common Stock
. Proceeds from the sale of shares of Common
Stock pursuant to Options shall constitute general funds of the Company.
(b) Corporate Action Constituting Grant of Options
. Corporate action constituting a grant by
the Company of an Option to any Participant shall be deemed completed as of the date of such
corporate action, unless otherwise determined by the Board, regardless of when the instrument,
certificate, or letter evidencing the Option is communicated to, or actually received or accepted
by, the Participant.
(c) Stockholder Rights
. No Participant shall be deemed to be the holder of, or to have any of
the rights of a holder with respect to, any shares of Common Stock subject to such
Option unless and until such Participant has exercised the Option pursuant to its terms and
the Participant shall not be deemed to be a stockholder of record until the issuance of the Common
Stock pursuant to such exercise has been entered into the books and records of the Company.
8.
(d) No Employment or Other Service Rights
. Nothing in the Plan, any Option Agreement or other
instrument executed thereunder or in connection with any Option granted pursuant to the Plan shall
confer upon any Participant any right to continue to serve the Company or an Affiliate in the
capacity in effect at the time the Option was granted or shall affect the right of the Company or
an Affiliate to terminate (i) the employment of an Employee with or without notice and with or
without cause, (ii) the service of a Consultant pursuant to the terms of such Consultants
agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the
Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the
state in which the Company or the Affiliate is incorporated, as the case may be.
(e) Incentive Stock Option $100,000 Limitation
. To the extent that the aggregate Fair Market
Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock
Options are exercisable for the first time by any Optionholder during any calendar year (under all
plans of the Company and any Affiliates) exceeds one hundred thousand dollars ($100,000), the
Options or portions thereof that exceed such limit (according to the order in which they were
granted) shall be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of
the applicable Option Agreement(s).
(f) Investment Assurances
. The Company may require a Participant, as a condition of
exercising or acquiring Common Stock under any Option, (i) to give written assurances satisfactory
to the Company as to the Participants knowledge and experience in financial and business matters
and/or to employ a purchaser representative reasonably satisfactory to the Company who is
knowledgeable and experienced in financial and business matters and that he or she is capable of
evaluating, alone or together with the purchaser representative, the merits and risks of exercising
the Option; and (ii) to give written assurances satisfactory to the Company stating that the
Participant is acquiring Common Stock subject to the Option for the Participants own account and
not with any present intention of selling or otherwise distributing the Common Stock. The
foregoing requirements, and any assurances given pursuant to such requirements, shall be
inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock
under the Option has been registered under a then currently effective registration statement under
the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for
the Company that such requirement need not be met in the circumstances under the then applicable
securities laws. The Company may, upon advice of counsel to the Company, place legends on stock
certificates issued under the Plan as such counsel deems necessary or appropriate in order to
comply with applicable securities laws, including, but not limited to, legends restricting the
transfer of the Common Stock.
(g) Withholding Obligations
. Unless prohibited by the terms of an Option Agreement, the
Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation
relating to an Option by any of the following means (in addition to the Companys right to withhold
from any compensation paid to the Participant by the Company) or by a combination of such means:
(i) causing the Participant to tender a cash payment; (ii)
withholding shares of Common Stock from the shares of Common Stock issued or otherwise
issuable to the Participant in connection with the Option; (iii) withholding cash from an Option
settled in cash; or (iv) by such other method as may be set forth in the Option Agreement.
9.
(h) Electronic Delivery
. Any reference herein to a written agreement or document shall
include any agreement or document delivered electronically or posted on the Companys intranet.
(i) Deferrals
. To the extent permitted by applicable law, the Board, in its sole discretion,
may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting
or settlement of all or a portion of any Option may be deferred and may establish programs and
procedures for deferral elections to be made by Participants. Deferrals by Participants will be
made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the
Board may provide for distributions while a Participant is still an employee. The Board is
authorized to make deferrals of Options and determine when, and in what annual percentages,
Participants may receive payments, including lump sum payments, following the Participants
termination of employment or retirement, and implement such other terms and conditions consistent
with the provisions of the Plan and in accordance with applicable law.
(j) Compliance with Section 409A of the Code
. To the extent that the Board determines that
any Option granted under the Plan is subject to Section 409A of the Code, the Option Agreement
evidencing such Option shall incorporate the terms and conditions necessary to avoid the
consequences specified in Section 409A(a)(1) of the Code. To the extent practicable and without
adverse effects on the Plan or on Optionholders, the Plan and Option Agreements shall be
interpreted in a manner that avoids taxation under Section 409A of the Code and Department of
Treasury regulations and other interpretive guidance issued thereunder, including without
limitation any such regulations or other guidance that may be issued or amended after the Effective
Date. Notwithstanding any provision of the Plan to the contrary, in the event that following the
Effective Date the Board determines that any Option may be subject to Section 409A of the Code and
related Department of Treasury guidance (including such Department of Treasury guidance as may be
issued after the Effective Date), the Board may adopt such amendments to the Plan and the
applicable Option Agreement or adopt other policies and procedures (including amendments, policies
and procedures with retroactive effect), or take any other actions, that the Board determines are
necessary or appropriate to (i) exempt the Option from Section 409A of the Code and/or preserve the
intended tax treatment of the benefits provided with respect to the Option, or (ii) comply with the
requirements of Section 409A of the Code and Department of Treasury regulations and other
interpretive guidance issued thereunder, including without limitation any such regulations or other
guidance that may be issued or amended after the Effective Date.
9.
Adjustments upon Changes in Common Stock; Other Corporate Events
.
(a) Capitalization Adjustments
. In the event of a Capitalization Adjustment, the Board shall
appropriately adjust: (i) the class(es) and maximum number of securities subject to the Plan
pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued
pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), (iii) the
class(es) and maximum number of securities that may be awarded to any person pursuant to
Section 3(d) and (iv) the class(es) and number of securities and price per share of stock subject
to outstanding Options. The Board shall make such adjustments, and its determination shall be
final, binding and conclusive.
10.
(b) Dissolution or Liquidation
. Except as otherwise provided in the Option Agreement, in the
event of a dissolution or liquidation of the Company, all outstanding Options shall terminate
immediately prior to the completion of such dissolution or liquidation,
provided, however
, that the
Board may, on an extraordinary basis, in its sole discretion, determine on a case by case basis
whether to cause some or all Options to become fully vested, and/or exercisable (to the extent such
Options have not previously expired or terminated) before the dissolution or liquidation is
completed but contingent on its completion.
(c) Corporate Transaction
. The following provisions may apply to Options in the event of a
Corporate Transaction unless otherwise provided in the instrument evidencing the Option or any
other written agreement between the Company or any Affiliate and the Participant or unless
otherwise expressly provided by the Board at the time of grant of an Option. If there is a
Corporate Transaction, then the Board, or the board of directors of any corporation or entity
assuming the obligations of the Company, may take any one or more of the following actions as to
outstanding Options in its sole and absolute discretion:
(i) Options May Be Continued, Assumed or Substituted
. Any surviving corporation or acquiring
corporation (or the surviving or acquiring corporations parent company) may assume or continue any
or all Options outstanding under the Plan or may substitute similar stock awards for Options
outstanding under the Plan (including but not limited to, awards to acquire the same consideration
paid to the stockholders of the Company pursuant to the Corporate Transaction) in connection with
such Corporate Transaction. A surviving corporation or acquiring corporation (or its parent) may
choose to assume or continue only a portion of an Option or substitute a similar stock award for
only a portion of an Option, or may assume, continue or substitute some Options and not others.
The terms of any assumption, continuation or substitution shall be set by the Board in accordance
with the provisions of Section 2.
(ii) Accelerated Vesting of Options
. On an extraordinary basis, the Board may, in its sole
discretion, determine case by case whether the vesting of any or all Options, and the time at which
such Options may be exercised, may be accelerated in full or in part to a date on or prior to the
effective time of such Corporate Transaction (contingent upon the effectiveness of the Corporate
Transaction) as the Board shall determine; provided, however, that for purposes of this Section,
the Agreement evidencing such option may provide for acceleration of vesting without acceleration
of exercisability or may contain additional restrictions on the holding period for such Shares as
may be deemed advisable by the Board and as may be necessary to comply with Section 409A of the
Code.
(iii) Termination of Options
. The Board may provide that all Options (including vested
Options that are not exercised) shall immediately terminate and be of no further force or effect as
of the effective time of the Corporate Transaction.
11.
(iv) Payment for Options in Lieu of Exercise
. The Board may provide that the holder of an
Option may not exercise such Option but will receive a payment, in such form as may be determined
by the Board, equal in value to the excess, if any, of (A) the value of the property the holder of
the Option would have received upon the exercise of the Option (including, at the discretion of the
Board, any unvested portion of such Option), over (B) any exercise price payable by such holder in
connection with such exercise. To the extent permitted by Section 409A of the Code, the Board may
delay the payment under this provision to take into account escrows, earn-outs or other holdbacks
or contingencies applicable to the Corporate Transaction.
(d) Change in Control
. On an extraordinary basis, the Board may, in its sole discretion,
determine case by case whether an Option may be subject to additional acceleration of vesting and
exercisability upon or after a Change in Control as may be provided in the Option Agreement for
such Option or as may be provided in any other written agreement between the Company or any
Affiliate and the Participant, but in the absence of such an express provision, no such
acceleration shall occur.
10.
Termination or Suspension of the Plan
.
(a) Plan Term
. Unless sooner terminated by the Board pursuant to Section 2, the Plan shall
automatically terminate on the day before the tenth (10th) anniversary of the date the Plan is
adopted by the Board or approved by the stockholders of the Company, whichever is earlier. No
Options may be granted under the Plan while the Plan is suspended or after it is terminated.
(b) No Impairment of Rights
. Termination of the Plan shall not impair rights and obligations
under any Option granted while the Plan is in effect except with the written consent of the
affected Participant.
11.
Effective Date of Plan
.
This Plan shall become effective on the Effective Date.
12.
Choice of Law
.
The law of the State of Delaware shall govern all questions concerning the construction,
validity and interpretation of this Plan, without regard to such states conflict of laws rules.
13.
Definitions
.
As used in the Plan, the definitions contained in this Section 13 shall
apply to the capitalized terms indicated below:
(a)
Affiliate
means, at the time of determination, any parent or subsidiary of the
Company as such terms are defined in Rule 405 of the Securities Act. The Board shall have the
authority to determine the time or times at which parent or subsidiary status is determined
within the foregoing definition.
(b)
Board
means the Board of Directors of the Company.
12.
(c)
Capitalization Adjustment
means any change that is made in, or other events that occur
with respect to, the Common Stock subject to the Plan or subject to any Option after the Effective
Date without the receipt of consideration by the Company (through merger, consolidation,
reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than
cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in
corporate structure or other transaction not involving the receipt of consideration by the
Company). Notwithstanding the foregoing, the conversion of any convertible securities of the
Company shall not be treated as a transaction without receipt of consideration by the Company.
For the avoidance of doubt, the 1-for-15 reverse stock split of the Common Stock effected on June
19, 2007 shall not be considered to have occurred after the Effective Date and therefore shall not
be considered a Capital Adjustment.
(d)
Cause
shall have the meaning set forth in any employment agreement or offer letter
between a Participant and the Company or an Affiliate to the extent then effective;
provided,
however,
that if any such employment agreement or offer letter does not contain a definition of
Cause, then the term shall mean with respect to a Participant, the occurrence of any of the
following events: (i) such Participants commission of any felony or any crime involving fraud,
dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii) such
Participants attempted commission of, or participation in, a fraud or act of dishonesty against
the Company; (iii) such Participants intentional, material violation of any contract or agreement
between the Participant and the Company or of any statutory duty owed to the Company; (iv) such
Participants unauthorized use or disclosure of the Companys confidential information or trade
secrets; or (v) such Participants gross misconduct. The determination that a termination of the
Participants Continuous Service is either for Cause or without Cause shall be made by the Company
in its sole discretion. Any determination by the Company that the Continuous Service of a
Participant was terminated by reason of dismissal without Cause for the purposes of outstanding
Options held by such Participant shall have no effect upon any determination of the rights or
obligations of the Company or such Participant for any other purpose.
(e)
Change in Control
means the occurrence, in a single transaction or in a series of
related transactions, of any one or more of the following events:
(i)
any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the
Company representing more than fifty percent (50%) of the combined voting power of the Companys
then outstanding securities other than by virtue of a merger, consolidation or similar transaction.
Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A) on account of
the acquisition of securities of the Company by an investor, any affiliate thereof or any other
Exchange Act Person from the Company in a transaction or series of related transactions the primary
purpose of which is to obtain financing for the Company through the issuance of equity securities,
or (B) solely because the level of Ownership held by any Exchange Act Person (the
Subject Person
)
exceeds the designated percentage threshold of the outstanding voting securities as a result of a
repurchase or other acquisition of voting securities by the Company reducing the number of shares
outstanding, provided that if a Change in Control would occur (but for the operation of this
sentence) as a result of the acquisition of voting securities by the Company, and after such share
acquisition, the Subject Person becomes the Owner of any additional voting securities that,
assuming the repurchase or other acquisition had not occurred,
increases the percentage of the then outstanding voting securities Owned by the Subject Person
over the designated percentage threshold, then a Change in Control shall be deemed to occur;
13.
(ii)
there is consummated a merger, consolidation or similar transaction involving (directly
or indirectly) the Company and, immediately after the consummation of such merger, consolidation or
similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly
or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%)
of the combined outstanding voting power of the surviving Entity in such merger, consolidation or
similar transaction or (B) more than fifty percent (50%) of the combined outstanding voting power
of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each
case in substantially the same proportions as their Ownership of the outstanding voting securities
of the Company immediately prior to such transaction;
(iii)
the stockholders of the Company approve or the Board approves a plan of complete
dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company
shall otherwise occur, except for a liquidation into a parent corporation; or
(iv)
there is consummated a sale, lease, exclusive license or other disposition of all or
substantially all of the consolidated assets of the Company and its Subsidiaries, other than a
sale, lease, license or other disposition of all or substantially all of the consolidated assets of
the Company and its Subsidiaries to an Entity, more than fifty percent (50%) of the combined voting
power of the voting securities of which are Owned by stockholders of the Company in substantially
the same proportions as their Ownership of the outstanding voting securities of the Company
immediately prior to such sale, lease, license or other disposition.
For the avoidance of doubt, the term Change in Control shall not include a sale of assets,
merger or other transaction effected exclusively for the purpose of changing the domicile of the
Company.
Notwithstanding the foregoing or any other provision of this Plan, the definition of Change in
Control (or any analogous term) in an individual written agreement between the Company or any
Affiliate and the Participant shall supersede the foregoing definition with respect to Options
subject to such agreement;
provided, however
, that if no definition of Change in Control or any
analogous term is set forth in such an individual written agreement, the foregoing definition shall
apply.
(f)
Code
means the Internal Revenue Code of 1986, as amended.
(g)
Committee
means a committee of one (1) or more Directors to whom authority has been
delegated by the Board in accordance with Section 2(c).
(h)
Common Stock
means the common stock of the Company.
(i)
Company
means Northwest Biotherapeutics, Inc., a Delaware corporation.
14.
(j)
Consultant
means any person, including an advisor, who is (i) engaged by the Company or
an Affiliate to render consulting or advisory services and is compensated for such services, or
(ii) serving as a member of the board of directors of an Affiliate and is compensated for such
services. However, service solely as a Director, or payment of a fee for such service, shall not
cause a Director to be considered a Consultant for purposes of the Plan.
(k)
Continuous Service
means that the Participants service with the Company or an
Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A
change in the capacity in which the Participant renders service to the Company or an Affiliate as
an Employee, Consultant or Director or a change in the entity for which the Participant renders
such service, provided that there is no interruption or termination of the Participants service
with the Company or an Affiliate, shall not terminate a Participants Continuous Service. For
example, a change in status from an employee of the Company to a consultant to an Affiliate or to a
Director shall not constitute an interruption of Continuous Service. To the extent permitted by
law, the Board or the chief executive officer of the Company, in that partys sole discretion, may
determine whether Continuous Service shall be considered interrupted in the case of any leave of
absence approved by that party, including sick leave, military leave or any other personal leave.
Notwithstanding the foregoing, a leave of absence shall be treated as Continuous Service for
purposes of vesting in an Option only to such extent as may be provided in the Companys leave of
absence policy, in the written terms of any leave of absence agreement or policy applicable to the
Participant, or as otherwise required by law.
(l)
Corporate Transaction
means the occurrence, in a single transaction or in a series of
related transactions, of any one or more of the following events:
(i)
a sale or other disposition of all or substantially all, as determined by the Board in its
sole discretion, of the consolidated assets of the Company and its Subsidiaries;
(ii)
a sale or other disposition of at least fifty percent (50%) of the outstanding securities
of the Company;
(iii)
the consummation of a merger, consolidation or similar transaction following which the
Company is not the surviving corporation; or
(iv)
the consummation of a merger, consolidation or similar transaction following which the
Company is the surviving corporation but the shares of Common Stock outstanding immediately
preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of
the merger, consolidation or similar transaction into other property, whether in the form of
securities, cash or otherwise.
(m)
Covered Employee
shall have the meaning provided in Section 162(m)(3) of the Code and
the regulations promulgated thereunder.
(n)
Director
means a member of the Board.
(o)
Disability
means the permanent and total disability of a person within the meaning of
Section 22(e)(3) of the Code.
15.
(p)
Effective Date
means the later of (i) the date of approval of this Plan by the Board,
and (ii) the date the Common Stock is admitted to the Alternative Investments Market of the London
Stock Exchange. Notwithstanding the foregoing, no Common Stock shall be issued pursuant to an
Option unless and until the Plan has been approved by the stockholders of the Company, which
approval shall be within twelve (12) months before or after the date the Plan is adopted by the
Board.
(q)
Employee
means any person employed by the Company or an Affiliate. However, service
solely as a Director, or payment of a fee for such services, shall not cause a Director to be
considered an Employee for purposes of the Plan.
(r)
Entity
means a corporation, partnership, limited liability company or other entity.
(s)
Exchange Act
means the Securities Exchange Act of 1934, as amended.
(t)
Exchange Act Person
means any natural person, Entity or group (within the meaning of
Section 13(d) or 14(d) of the Exchange Act), except that Exchange Act Person shall not include
(i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or
any Subsidiary of the Company or any trustee or other fiduciary holding securities under an
employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter
temporarily holding securities pursuant to an offering of such securities, (iv) an Entity Owned,
directly or indirectly, by the stockholders of the Company in substantially the same proportions as
their Ownership of stock of the Company; or (v) any natural person, Entity or group (within the
meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date of the Plan
as set forth in Section 11, is the Owner, directly or indirectly, of securities of the Company
representing more than fifty percent (50%) of the combined voting power of the Companys then
outstanding securities.
(u)
Fair Market Value
means, as of any date, the value of the Common Stock determined as
follows:
(i)
If the Common Stock is listed on any established stock exchange or traded on any
established market, the Fair Market Value of a share of Common Stock shall be the closing sales
price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or
market (or the exchange or market with the greatest volume of trading in the Common Stock) for the
last market trading day prior to the date of determination, as reported in
The Wall Street Journal
or such other source as the Board deems reliable.
(ii)
In the absence of such markets for the Common Stock, the Fair Market Value shall be
determined by the Board in good faith.
(v)
Incentive Stock Option
means an option granted pursuant to Section 5 of the Plan that is
intended to be, and qualifies as, an incentive stock option within the meaning of Section 422 of
the Code and the regulations promulgated thereunder.
16.
(w)
Non-Employee Director
means a Director who either (i) is not a current employee or
officer of the Company or an Affiliate, does not receive compensation, either
directly or indirectly, from the Company or an Affiliate for services rendered as a consultant
or in any capacity other than as a Director (except for an amount as to which disclosure would not
be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act
(
Regulation S-K
)), does not possess an interest in any other transaction for which disclosure
would be required under Item 404(a) of Regulation S-K, and is not engaged in a business
relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or
(ii) is otherwise considered a non-employee director for purposes of Rule 16b-3.
(x)
Nonstatutory Stock Option
means any option granted pursuant to Section 5 of the Plan
that does not qualify as an Incentive Stock Option.
(y)
Officer
means a person who is an officer of the Company within the meaning of Section 16
of the Exchange Act and the rules and regulations promulgated thereunder.
(z)
Option
means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares
of Common Stock granted pursuant to the Plan.
(aa)
Option Agreement
means a written agreement between the Company and an Optionholder
evidencing the terms and conditions of an Option grant. Each Option Agreement shall be subject to
the terms and conditions of the Plan.
(bb)
Optionholder
means a person to whom an Option is granted pursuant to the Plan or, if
permitted under the terms of this Plan, such other person who holds an outstanding Option.
(cc)
Outside Director
means a Director who either (i) is not a current employee of the
Company or an affiliated corporation (within the meaning of Treasury Regulations promulgated
under Section 162(m) of the Code), is not a former employee of the Company or an affiliated
corporation who receives compensation for prior services (other than benefits under a
tax-qualified retirement plan) during the taxable year, has not been an officer of the Company or
an affiliated corporation, and does not receive remuneration from the Company or an affiliated
corporation, either directly or indirectly, in any capacity other than as a Director, or (ii) is
otherwise considered an outside director for purposes of Section 162(m) of the Code.
(dd)
Own
,
Owned
,
Owner
,
Ownership
A person or Entity shall be deemed to Own, to
have Owned, to be the Owner of, or to have acquired Ownership of securities if such person or
Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or
otherwise, has or shares voting power, which includes the power to vote or to direct the voting,
with respect to such securities.
(ee)
Participant
means a person to whom an Option is granted pursuant to the Plan or, if
applicable, such other person who holds an outstanding Option.
(ff)
Plan
means this Northwest Biotherapeutics, Inc. 2007 Stock Option Plan.
(gg)
Rule 16b-3
means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule
16b-3, as in effect from time to time.
17.
(hh)
Securities Act
means the Securities Act of 1933, as amended.
(ii)
Subsidiary
means, with respect to the Company, (i) any corporation of which more than
fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a
majority of the board of directors of such corporation (irrespective of whether, at the time, stock
of any other class or classes of such corporation shall have or might have voting power by reason
of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company,
and (ii) any partnership, limited liability company or other entity in which the Company has a
direct or indirect interest (whether in the form of voting or participation in profits or capital)
of more than fifty percent (50%).
(jj)
Ten Percent Stockholder
means a person who Owns (or is deemed to Own pursuant to
Section 424(d) of the Code) stock possessing more than ten percent (10%) of the total combined
voting power of all classes of stock of the Company or any Affiliate.
18.
EXHIBIT 14.1
Northwest Biotherapeutics, Inc.
Code of Ethics
Effective as of June 22, 2007
I.
Introduction
A. The Code and Compliance with the Code
Northwest Biotherapeutics, Inc. (
we
,
us
or the
Company
) is committed to conducting our
business with honesty and integrity. These values are important to us. This Code of Ethics (the
Code
) reflects the business practices and principles of behavior that support this commitment.
Our Board of Directors is responsible for setting the standards of conduct contained in this Code
and for updating these standards as appropriate to reflect legal and regulatory developments. We
expect every employee and member of our Board of Directors (each member of our Board of Directors,
a
director
) to read and understand this Code and its application to the performance of his or her
business responsibilities. Our Board of Directors and senior management are committed to assisting
employees in developing a clear understanding of the fundamental requirements of this Code, and in
providing education to employees concerning their responsibilities as members of the Companys
community. We will hold each of our employees and directors accountable for adherence to this Code.
Those who violate this Code will be subject to disciplinary action, up to and including termination
of employment.
This Code does not describe every practice or principle related to honest and ethical conduct. This
Code is an integral part of our Employee Handbook. The following additional policies found in our
Employee Handbook supplement or amplify this Code in certain areas and should be read in
conjunction with this Code: Prohibited Conduct, Confidentiality, Publicity/Statements to the Media
and Insider Trading Policy.
Employees and directors may seek guidance regarding this Code by contacting his or her immediate
supervisor or the Compliance Officer (see below).
B. Compliance Officer
Any questions about this Code or the appropriate course of conduct in a particular situation should
be directed to an employees immediate supervisor or the Compliance Officer. The Board of Directors
has designated our Chief Financial Officer as the Compliance Officer. Employees or directors may
make any report or complaint provided for in this Code to the Compliance Officer. The Compliance
Officer will refer complaints submitted, as appropriate, to the Board of Directors or the Audit
Committee of the Board of Directors (the
Audit Committee
).
II.
Standards of Ethical Conduct
A. Compliance with Applicable Law
All employees must comply with all of the laws, rules and regulations of the United States and
other countries, as well as the states, counties, cities and other jurisdictions, applicable to the
us or our subsidiaries.
This Code does not summarize all laws, rules and regulations applicable to us or our business. You
should consult the various guidelines we have prepared on specific laws, rules and regulations
which you can find summarized in the Employee Handbook.
Each employee and director is personally liable for intentional violations of the law. Employees in
a supervisory capacity and directors may be liable for violations committed by employees under
their supervision. Every employee and director is expected to be diligent in preventing, detecting
and promptly reporting violations of the law or instances of non-conformance.
Please consult with your supervisor or the Compliance Officer if you have questions about laws that
you think may be applicable to us or our business.
B. Public Company Reporting
We are a public company. It is of critical importance that our filings in the United States with
the Securities and Exchange Commission and in the UK with the London Stock Exchange (the
LSE
) be
full, fair, accurate, timely and understandable. Depending on their respective positions with us,
employees and directors may be called upon to provide information necessary to assure that our
public reports meet these requirements. We expect employees and directors to take this
responsibility very seriously and to provide prompt and accurate answers to inquiries related to
our public disclosure requirements. Employees and directors are prohibited from directly or
indirectly including any false or materially misleading statement in any public disclosure by us
and from omitting, or causing others to omit, any material fact necessary to prevent a statement
made in connection with any public disclosure from being misleading. Employees and directors
involved in the preparation of reports and documents filed with, or submitted to, the Securities
and Exchange Commission, and The Nasdaq Stock Market or the LSE, and in other public communications
made by us, must prepare those statements in accordance with all applicable laws, rules and
regulations.
Employees and directors involved in the preparation of our financial statements must also prepare
those statements in accordance with Generally Accepted Accounting Principles, consistently applied,
and any other applicable accounting standards and rules so that the financial statements
materially, fairly and completely reflect our business transactions and financial condition.
Further, Company policy prohibits any employee or director from knowingly making or causing others
to make a misleading, incomplete or false statement to an accountant or an attorney in connection
with an audit or any filing with any governmental or regulatory entity, including the Securities
and Exchange Commission, The Nasdaq Stock Market and the LSE.
In addition, an employee or director must not omit or cause others to omit any material fact that
is necessary to prevent a statement made in connection with any audit, public filing or examination
of our financial statements from being misleading.
C. Accuracy of Business Records
All of our books, invoices, records, accounts, funds, assets and laboratory notebooks must be
created and maintained to reflect fairly and accurately and in reasonable detail the underlying
activity and transactions. No entries may be made that intentionally conceal or disguise the true
nature of any of our activities or transactions. Records must be maintained to comply with
applicable statutory, regulatory or contractual requirements, as well as those pursuant to prudent
scientific and business practices. Our policy prohibits any employee or director from directly or
indirectly falsifying or causing others to falsify any of our documentation.
In addition, if an employee or director believes that our books and records are not being
maintained in accordance with these requirements, the employee or director should report the matter
directly to their supervisor, to the Compliance Officer or to the Chair of the Audit Committee.
Destruction or falsification of any document that is potentially relevant to a violation of law or
a government investigation may lead to prosecution for obstruction of justice. Therefore, if an
employee or director has reason to believe that a violation of the law has been committed or that a
government criminal or regulatory investigation has been, or is about to be, commenced, he or she
must retain all records (including computer records) that are or could be relevant to an
investigation of the matter, whether conducted by us or by a governmental authority. Questions with
regard to destruction or retention of documents in this context should be directed to the
Compliance Officer.
D. Research Integrity
Research integrity is fundamental to the scientific process and our ability to bring products to
market. All of our research and development must be conducted according to all applicable laws and
regulations and to the generally accepted ethical standards of the scientific community. Scientific
misconduct, such as the fabrication, falsification or plagiarism in proposing, conducting or
reporting research is prohibited.
E. Conflicts of Interest
A conflict of interest may exist whenever the private interests of an employee or director
conflict in any way (or even appear to conflict) with our interests. While our employees and
directors should be free to make personal investments and enjoy social relations and normal
business courtesies, they must not have any personal interests that adversely influence the
performance of their job responsibilities. A conflict situation can arise when an employee or
director takes actions or has interests that may make it difficult to perform work objectively and
effectively. Conflicts of interest may also arise when an employee or director, or a member of his
or her family, receives improper personal benefits as a result of his or her position in the
Company, whether received from us or a third party. Gifts, loans to, or guarantees of obligations
of, employees and directors may create conflicts of interest. In addition, it is a conflict of
interest for an employee to work simultaneously for us and a
competitor or one of our customers or suppliers absent an express written consent or waiver from
us.
Conflicts of interest may arise when doing business with or competing with organizations in which
family members of employees or directors have an ownership or employment interest. Family members
include spouses, domestic partners, parents, children, siblings and in-laws. Employees and
directors may not conduct business on our behalf and may not use their influence to get us to do
business with family members or an organization with which an employee or director or their family
member has a significant financial or employment interest unless specific approval has been granted
in advance. As a guide, a significant financial interest is defined as ownership by an employee
or director and/or their family member of more than 1% of the outstanding securities or capital
value of a business entity or that represents more than 5% of the total assets of the employee or
director and/or family member.
We encourage good supplier relations. However, employees and directors may not benefit personally,
whether directly or indirectly, from any purchase of goods or services for or from us. Employees
and directors whose responsibilities include purchasing, or who have contact with suppliers or
service providers, must not exploit their position for personal gain. Under no circumstances may
any employee or director receive cash or cash equivalents from any supplier, whether directly or
indirectly.
Conflicts of interest are to be scrupulously avoided, and if a conflict of interest is unavoidable,
it must be disclosed to us at the earliest opportunity so that a determination can be made whether
it is permissible. Employees who become aware of a conflict or potential conflict of interest must
report the matter to their supervisor or to the Compliance Officer. Directors must report any
conflicts of interest, or potential conflicts of interest, to the Compliance Officer or to the
Board of Directors. Supervisors who receive reports regarding any conflicts of interest, or
potential conflicts of interest, are to report the matter to the Compliance Officer. The Compliance
Officer will review any such information, conduct an investigation if necessary and report the
results to the Chief Executive Officer. The Compliance Officer and the Chief Executive Officer will
determine if a conflict of interest exists, or will exist, and if so, whether the Company should
approve the transaction or relationship notwithstanding the conflict of interest. The Compliance
Officer will report to the Board of Directors periodically about reported conflicts or potential
conflicts. Conflicts of interest may not always be clear-cut, so if you have a question, you should
consult with your supervisor or the Compliance Officer.
F. Corporate Opportunity
Except as may be approved by the Board of Directors or a committee of independent directors,
employees and directors are prohibited from (a) taking for themselves personally any opportunities
that belong to us or are discovered through the use of corporate property, information or position;
(b) using corporate property, information or position for personal gain; and (c) competing with the
Company.
G. Confidentiality
All employees, under the Non-disclosure Agreement they signed when they joined the Company, and all
directors, must maintain the confidentiality of confidential information
entrusted to them by us or our suppliers or customers, except when disclosure is authorized by us
or required by laws, regulations or legal proceedings. As more fully described in the
Non-disclosure Agreement, confidential information includes, but is not limited to, information
and facts concerning business plans, customers, future customers, suppliers, licensors, licensees,
partners, investors, affiliates or others, training methods and materials, financial information,
sales prospects, client lists, inventions, or any other scientific, technical, trade or business
secret or confidential or proprietary information. Whenever feasible, employees and directors
should consult the Compliance Officer if they believe they have a legal obligation to disclose
confidential information.
H. Fair Dealing
All employees and directors should endeavor to deal fairly with each other and with our customers,
suppliers, and competitors. None should take unfair advantage of anyone through manipulation,
concealment, abuse of privileged information, misrepresentation of material facts or any other
unfair dealing practice. Stealing proprietary information, misusing trade secret information that
was obtained without the owners consent, or inducing such disclosures by past or present employees
of other companies is prohibited.
I. Protection and Proper Use of Company Assets
All Employees should protect our assets and ensure their efficient use. Theft, carelessness and
waste have a direct impact on our financial results. All of our assets should be used for
legitimate business purposes. Employees and directors are not permitted to take or make use of,
steal, or knowingly misappropriate our assets, including any of our confidential information, for
their own use, the use of another or for an improper or illegal purpose. Employees and directors
are not permitted to remove or dispose of anything of value belonging to us without our consent. No
employee or director may destroy any of our assets without permission. Incidental personal use may
be appropriate for certain of our assets, but you should check with a supervisor to determine what
may be appropriate.
J. Frauds and Thefts
Company policy prohibits fraudulent activity and requires that incidents of fraud and theft
relating to us are promptly investigated, reported and, where appropriate, prosecuted. Fraudulent
activities can include, but are not limited to: embezzlement; forgery or alteration of negotiable
instruments such as Company checks or drafts; misappropriation of our, employee, customer,
collaborator or supplier assets; conversion to personal use of cash, securities, supplies or any
other of our asset; unauthorized handling or reporting of our transactions; or falsification of our
records.
K. Relations With Government Agencies Generally
We must take special care to comply with all the special legal and contractual obligations
applicable to transactions with government authorities. Good communications and relationships with
federal, state, provincial and municipal elected and appointed officials are important to us.
Violations of such laws may result in penalties and fines, as well as debarment or suspension from
government contracting, or possible criminal prosecution of individual employees or directors or
us.
L. Foreign Corrupt Practices Act
We, our employees, directors and agents must strictly comply with the United States Foreign Corrupt
Practices Act of 1977 (FCPA). The FCPA applies to all U.S. citizens and employees and agents of
U.S. corporations regardless of their nationality and prohibits the giving or promising of anything
of value to any foreign government official or candidate for public office in order to obtain or
retain business. All employees and directors must be diligent and vigilant in selecting and
managing anyone retained to assist in obtaining or maintaining government contracts or other
business opportunities in foreign countries.
M. Records and Submissions
We are required to compile and maintain numerous records and substantial information, and to file
reports and applications with various government agencies. In most cases, the laws under which
these agencies operate make it a crime to knowingly submit false or incomplete information, to fail
to submit required information, or to fail to submit information within the required time period.
Accordingly, all employees or directors who prepare information, records, or submissions for
governmental agencies, or who otherwise deal with such agencies, must do so diligently, accurately,
completely, and with absolute integrity.
N. Responding to Government and Other Inquiries
It is Company policy to cooperate with all reasonable requests concerning our operations from
United States, state, municipal and foreign government agencies. Employees and directors must
immediately (and before any responsive action is taken) forward any such requests, including
requests for interviews or access for government officials to our facilities and documents, to the
Compliance Officer.
For those employees who deal with regulatory entities and governmental authorities on a routine
basis as part of their job function, referral to the Compliance Officer is appropriate where an
inquiry or contact is out of the ordinary course of business or involves a potential legal or
disciplinary action of any kind.
O. Tax Violations
We and our employees and directors, whether acting on behalf of the Company or individually, are
not permitted to (i) attempt to evade taxes or the payment of taxes; (ii) make false statements to
local tax authorities regarding any matter; (iii) file fraudulent returns, statements, lists or
other documents; (iv) conceal property or withhold records from local tax authorities; (v)
willfully fail to file tax returns, keep required records or supply information to local tax
authorities; or (vi) willfully fail to collect, account for or pay a tax. Moreover, employees and
directors may not interfere with the administration of the tax laws (e.g., bribing a tax agent).
Employees and directors are required to notify the Compliance Officer or the Chief Financial
Officer immediately of inquiries from a tax authority, including summons to testify or produce
books, accounts, records, memoranda or other papers.
III.
Reporting Violations of this Code
A. Procedure for Submitting Accounting Complaints
The Audit Committee is responsible for establishing procedures for the receipt, retention and
treatment of complaints regarding accounting, internal accounting controls or auditing matters.
Employees or directors who have concerns or complaints regarding such matters are encouraged to
promptly submit those concerns or complaints to the Audit Committee, which, subject to its duties
arising under applicable law, regulations and legal proceedings, will treat such submissions
confidentially.
Such concerns or complaints may be made anonymously by calling our complaints hotline, which is
available 24 hours a day, seven days a week and managed by an independent third-party vendor. The
hotline phone number and other instructions for calling the hotline are provided to each employee,
or you may contact our human resources department to obtain a copy of these instructions. Such
submissions will automatically be directed to the attention of the Compliance Officer, who will be
responsible for bringing such submissions to the attention of the Audit Committee, as appropriate.
In addition, the Compliance Officer will periodically report to the Audit Committee on all such
submissions.
B. Procedure for Reporting Other Illegal or Unethical Behavior
Employees and directors are encouraged to promptly contact a supervisor, manager, the Compliance
Officer or human resources if he or she believes that an employee or director has engaged in
illegal conduct or any violation of this Code. Such reports may be made anonymously, as described
below. Confidentiality will be protected, subject to applicable law, regulation or legal
proceeding.
We have established the following procedures for reporting violations or potential violations of
this Code. Employees may report a potential violation to their supervisor. Employees who are not
comfortable reporting to their supervisor or who do not get a satisfactory response may contact the
Compliance Officer or the Chair of the Audit Committee or use the anonymous reporting procedures
described above.
Supervisors who receive information concerning activity that may violate this Code or an applicable
law, rule or regulation should report the matter to the Compliance Officer. Supervisors who are not
comfortable reporting to Compliance Officer or who do not get a satisfactory response may contact
the Chief Executive Officer or the Chair of the Audit Committee. Moreover, any violations or
possible violations that implicate the Compliance Officer, the Chief Executive Officer or senior
executive officers may be made directly to the Chair of the Audit Committee or use the anonymous
reporting procedures described below. Directors may report a potential violation to the Compliance
Officer or to the Chair of the Audit Committee.
Reports of potential violations of this Code or an applicable law, rule or regulation, by employees
or directors may be made anonymously to our complaints hotline as described above under Procedure
for Submitting Accounting Complaints.
All reports and inquiries will be handled confidentially to the greatest extent possible under the
circumstances. Reporting persons may choose to remain anonymous, though in some
cases that could make it more difficult for that individual to track the resolution of their
report. Reports should include as much information as possible regarding the potential violation.
No employee or director will be subject to retaliation or punishment for reporting in good faith
suspected unethical or illegal conduct or for coming forward to alert us of any questionable
situation.
IV.
Enforcement of this Code
Our Board of Directors and senior management encourage all employees and directors to study this
Code and to bring to their supervisors or the Compliance Officer any questions or concerns they may
have about the Code. Compliance with this Code is expected, in order to support our commitment to
honest and ethical practices in our business. Employees or directors who fail to comply with these
policies will be subject to disciplinary action, up to and including termination of employment or,
if warranted, legal proceedings by us. The following are examples of conduct that may result in
discipline:
|
|
|
actions that violate this Code;
|
|
|
|
|
requesting others to violate this Code;
|
|
|
|
|
failure to report a known or suspected violation of this Code;
|
|
|
|
|
failure to cooperate in investigations of possible violations of this Code;
and
|
|
|
|
|
failure to demonstrate the leadership and diligence needed to ensure
compliance with this Code and applicable law.
|
We intend such disciplinary action to reflect our belief that all employees and directors should be
held accountable to the standards of conduct set forth herein. It is important to understand that
violation of certain of these policies may subject us and the individual employee or director
involved to civil liability and damages, regulatory sanction and/or criminal prosecution. We are
responsible for satisfying the regulatory reporting, investigative and other obligations that may
follow the identification of a violation. To ensure prompt and consistent enforcement of this Code,
the Audit Committee will monitor all disciplinary action regarding employees or directors for
violations of this Code.
A. No Retaliation Policy
Company personnel may report any violation of this Code or other misconduct openly or anonymously
without fear of retaliation. We will not discipline, discriminate against or retaliate against any
employee who reports such conduct or who cooperates in any investigation or inquiry regarding such
conduct, unless it is determined that the report was made with knowledge that it was false.
Anyone who participates in any form of retaliation is subject to disciplinary action including
termination. No hardship, loss of benefit, or adverse employment action may be imposed on an
employee for the following:
|
|
|
filing or otherwise participating in a bona fide complaint;
|
|
|
|
acting as a witness in an investigation of a complaint; or
|
|
|
|
|
serving as an investigator of a complaint.
|
If any Company personnel believes that he or she is being retaliated against, or is aware of such
retaliation, you should immediately report the issue through the process described above under
Reporting Violations of this Code.
B. Waivers/Modifications
In certain limited situations and on a case-by-case basis, we may waive application of this Code to
employees or directors. Any waiver of this Code for executive officers, senior financial officers
or directors requires the express written approval of the Board of Directors or the Audit
Committee. Waivers of this Code for any other Company personnel requires the express written
approval of the Compliance Officer and the Chief Executive Officer, acting jointly. Furthermore, as
required by applicable law, we will promptly disclose to its stockholders any waivers granted to
any of its executive officers, senior financial officers or directors.
We are committed to continuously reviewing and updating our policies and procedures. Therefore,
this Code is subject to modification. Any amendment to provisions of this Code must be approved by
the Board of Directors and promptly disclosed to stockholders as required by applicable law.